Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Gene_full_name.refGene	Function_description.refGene	Disease_description.refGene	Tissue_specificity(Uniprot).refGene	Expression(egenetics).refGene	Expression(GNF/Atlas).refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	cytoBand	cosmic70	ExAC_ALL	ExAC_AFR	ExAC_AMR	ExAC_EAS	ExAC_FIN	ExAC_NFE	ExAC_OTH	ExAC_SAS	gnomAD_genome_ALL	gnomAD_genome_AFR	gnomAD_genome_AMR	gnomAD_genome_ASJ	gnomAD_genome_EAS	gnomAD_genome_FIN	gnomAD_genome_NFE	gnomAD_genome_OTH	avsnp147	CLNALLELEID	CLNDN	CLNDISDB	CLNREVSTAT	CLNSIG	HGMD_pro_2019.1
1	26629342	26629342	G	A	exonic	UBXN11		synonymous SNV	UBXN11:NM_001077262:exon2:c.C33T:p.T11T,UBXN11:NM_145345:exon3:c.C33T:p.T11T,UBXN11:NM_183008:exon3:c.C33T:p.T11T	1.20340272757806e-10	0.308498838569145	0.691501161310515	UBX domain protein 11	FUNCTION: May be involved in the reorganization of actin cytoskeleton mediated by RND1, RND2 AND RND3. Promotes RHOA activation mediated by GNA12 and GNA13 (By similarity). {ECO:0000250}.; 	.	.	ovary;colon;bone marrow;optic nerve;endometrium;cerebral cortex;larynx;bone;testis;brain;unclassifiable (Anatomical System);lymph node;islets of Langerhans;blood;skeletal muscle;pancreas;lung;placenta;visual apparatus;liver;cervix;head and neck;spleen;kidney;mammary gland;stomach;	.	0.10438	0.20558	1.201528238	93.00542581	1513.39604	7.23123	1p36.11		0.0094	0.0023	0.0016	0.0601	0.0070	0.0074	0.0056	0.0020	0.0079	0.0017	0.0024	0	0.0612	0.0069	0.0063	0.0122	rs117509001						
1	40315888	40315888	A	T	exonic	TRIT1		nonsynonymous SNV	TRIT1:NM_001312692:exon3:c.T366A:p.F122L,TRIT1:NM_001312691:exon5:c.T606A:p.F202L,TRIT1:NM_017646:exon5:c.T606A:p.F202L	9.42968680674274e-10	0.28367453303875	0.716325466018282	tRNA isopentenyltransferase 1	FUNCTION: Catalyzes the transfer of a dimethylallyl group onto the adenine at position 37 of both cytosolic and mitochondrial tRNAs, leading to the formation of N6-(dimethylallyl)adenosine (i(6)A). {ECO:0000269|PubMed:11111046}.; 	.	.	lymphoreticular;ovary;colon;retina;bone marrow;uterus;prostate;whole body;frontal lobe;cerebral cortex;endometrium;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;cartilage;islets of Langerhans;blood;skeletal muscle;pancreas;lung;trabecular meshwork;placenta;visual apparatus;liver;kidney;mammary gland;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;appendix;testis;atrioventricular node;	0.23650	0.14415	-0.003562597	53.72729417	1128.84131	6.41211	1p34.2		0.1041	0.1711	0.2057	0.2903	0.1005	0.0560	0.1049	0.0890	0.1085	0.1688	0.1611	0.0629	0.2781	0.0990	0.0564	0.0937	rs3738671						
1	55060251	55060251	C	T	exonic	ACOT11		nonsynonymous SNV	ACOT11:NM_015547:exon6:c.C494T:p.P165L,ACOT11:NM_147161:exon6:c.C494T:p.P165L	1.33339142705338e-10	0.53607299380681	0.463927006059851	acyl-CoA thioesterase 11	FUNCTION: Has acyl-CoA thioesterase activity towards medium (C12) and long-chain (C18) fatty acyl-CoA substrates.; 	.	TISSUE SPECIFICITY: Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue.; 	unclassifiable (Anatomical System);lymph node;ovary;lacrimal gland;colon;parathyroid;fovea centralis;choroid;lens;skin;retina;prostate;optic nerve;nasopharynx;thyroid;placenta;macula lutea;pituitary gland;liver;head and neck;spleen;kidney;mammary gland;stomach;	.	0.10496	0.13932	0.720128343	85.85751356	3575.80865	11.56510	1p32.3		0.0640	0.0334	0.1976	0.1836	0.0712	0.0270	0.0699	0.0720	0.0422	0.0278	0.1826	0.0099	0.1784	0.0576	0.0238	0.0621	rs2304306						
1	78201745	78201745	G	T	exonic	USP33		synonymous SNV	USP33:NM_201624:exon6:c.C450A:p.A150A,USP33:NM_015017:exon7:c.C543A:p.A181A,USP33:NM_201626:exon7:c.C543A:p.A181A	0.996116690829413	0.00388330907241222	9.81746251478828e-11	ubiquitin specific peptidase 33	FUNCTION: Deubiquitinating enzyme involved in various processes such as centrosome duplication, cellular migration and beta-2 adrenergic receptor/ADRB2 recycling. Involved in regulation of centrosome duplication by mediating deubiquitination of CCP110 in S and G2/M phase, leading to stabilize CCP110 during the period which centrioles duplicate and elongate. Involved in cell migration via its interaction with intracellular domain of ROBO1, leading to regulate the Slit signaling. Plays a role in commissural axon guidance cross the ventral midline of the neural tube in a Slit-dependent manner, possibly by mediating the deubiquitination of ROBO1. Acts as a regulator of G-protein coupled receptor (GPCR) signaling by mediating the deubiquitination of beta-arrestins (ARRB1 and ARRB2) and beta-2 adrenergic receptor (ADRB2). Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2. Upon dissociation, it is probably transferred to the translocated beta- arrestins, leading to beta-arrestins deubiquitination and disengagement from ADRB2. This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating thyroid hormone regulation. Mediates deubiquitination of both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. {ECO:0000269|PubMed:12865408, ECO:0000269|PubMed:19363159, ECO:0000269|PubMed:19424180, ECO:0000269|PubMed:23486064}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11739384}.; 	ovary;skin;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;germinal center;bladder;brain;amygdala;heart;tongue;spinal cord;pharynx;blood;lens;skeletal muscle;breast;macula lutea;liver;cervix;spleen;mammary gland;peripheral nerve;salivary gland;intestine;colon;parathyroid;choroid;fovea centralis;uterus;bone;testis;pineal gland;unclassifiable (Anatomical System);lymph node;cerebellum cortex;islets of Langerhans;hypothalamus;pancreas;lung;placenta;head and neck;kidney;aorta;stomach;	amygdala;occipital lobe;superior cervical ganglion;medulla oblongata;subthalamic nucleus;cerebellum peduncles;hypothalamus;prefrontal cortex;globus pallidus;pons;parietal lobe;cingulate cortex;	0.71345	0.11489	-1.440283256	3.963198868	84.59856	1.95841	1p31.1		0.3660	0.6916	0.2149	0.3797	0.3355	0.3078	0.3877	0.5059	0.4092	0.6844	0.2200	0.4702	0.3691	0.3253	0.2847	0.3701	rs2296227						
1	109716326	109716326	A	G	exonic	KIAA1324		synonymous SNV	KIAA1324:NM_001284352:exon6:c.A513G:p.S171S,KIAA1324:NM_020775:exon7:c.A819G:p.S273S	2.14864520738644e-08	0.998570003732984	0.00142997478056437	KIAA1324	FUNCTION: May protect cells from cell death by inducing cytosolic vacuolization and upregulating the autophagy pathway. {ECO:0000269|PubMed:21072319}.; 	.	TISSUE SPECIFICITY: Expressed in normal endometrium but overexpressed in endometroid tumors. {ECO:0000269|PubMed:16322283}.; 	.	.	0.18892	0.10823	-0.501537595	21.83887709	267.58763	3.50758	1p13.3		0.0011	0	0	0.0140	0	0	0.0011	0.0007	0.0007	0	0	0	0.0130	0	0	0	rs116928655						
1	154293675	154293675	G	A	exonic	AQP10		nonsynonymous SNV	AQP10:NM_080429:exon1:c.G44A:p.R15Q	0.0152782932027765	0.878522242818559	0.106199463978665	aquaporin 10	FUNCTION: Water channel required to promote glycerol permeability and water transport across cell membranes. May contribute to water transport in the upper portion of small intestine. Isoform 2 is not permeable to urea and glycerol. {ECO:0000269|PubMed:11573934, ECO:0000269|PubMed:12084581}.; 	.	TISSUE SPECIFICITY: Expressed exclusively in duodenum and jejunum. Highest expression in absorptive epithelial cells at the tips of villi in the jejunum.; 	unclassifiable (Anatomical System);lung;liver;testis;spleen;skeletal muscle;	.	0.10780	0.10375	0.104848986	61.49445624	4035.92542	12.59512	1q21.3		0.2921	0.2658	0.2131	0.2251	0.3732	0.2968	0.3102	0.3470	0.2985	0.2700	0.2368	0.1887	0.2246	0.3627	0.3122	0.3238	rs6668968						
1	156814027	156814027	G	A	exonic	INSRR		nonsynonymous SNV	INSRR:NM_014215:exon15:c.C2783T:p.P928L	4.91565760465697e-07	0.999920299072368	7.92093618710879e-05	insulin receptor-related receptor	FUNCTION: Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. {ECO:0000269|PubMed:21641549}.; 	.	.	.	.	0.62339	0.19592	-2.250890405	1.279782968	1815.11428	7.85768	1q23.1		0.1680	0.2461	0.1710	0.1154	0.1141	0.1613	0.1330	0.1953	0.1709	0.2398	0.1722	0.1689	0.1062	0.1149	0.1527	0.1408	rs56252149						
1	176857291	176857291	T	A	exonic	ASTN1		nonsynonymous SNV	ASTN1:NM_001286164:exon18:c.A2990T:p.D997V,ASTN1:NM_004319:exon18:c.A2990T:p.D997V,ASTN1:NM_207108:exon18:c.A2990T:p.D997V	0.999415997291979	0.000584002707053689	9.67762336583381e-13	astrotactin 1	FUNCTION: Neuronal adhesion molecule that is required for glial- guided migration of young postmitotic neuroblasts in cortical regions of developing brain, including cerebrum, hippocampus, cerebellum and olfactory bulb.; 	.	.	unclassifiable (Anatomical System);heart;ovary;hypothalamus;sympathetic chain;adrenal cortex;fovea centralis;choroid;lens;skeletal muscle;skin;retina;uterus;optic nerve;whole body;lung;frontal lobe;bone;macula lutea;visual apparatus;hippocampus;testis;brain;	amygdala;dorsal root ganglion;whole brain;medulla oblongata;superior cervical ganglion;thalamus;occipital lobe;cerebellum peduncles;hypothalamus;temporal lobe;pons;caudate nucleus;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;trigeminal ganglion;cingulate cortex;parietal lobe;cerebellum;	0.12514	0.11666	-1.095046929	6.97688134	570.07336	4.84399	1q25.2		0.0001	0	0	0.0017	0	0	0	0.0001	9.692e-05	0	0	0	0.0018	0	0	0	rs201838058						
1	186363119	186363119	C	G	exonic	C1orf27		nonsynonymous SNV	C1orf27:NM_001164246:exon8:c.C656G:p.S219C,C1orf27:NM_017847:exon9:c.C752G:p.S251C	1.38118318297717e-06	0.610686166159859	0.389312452656958	chromosome 1 open reading frame 27	FUNCTION: May play a role in the trafficking of a subset of G- protein coupled receptors. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:15718105}.; 	medulla oblongata;ovary;salivary gland;intestine;colon;parathyroid;skin;bone marrow;uterus;prostate;whole body;endometrium;bone;testis;brain;artery;bladder;unclassifiable (Anatomical System);heart;islets of Langerhans;spinal cord;pharynx;blood;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;visual apparatus;hippocampus;liver;cervix;kidney;stomach;aorta;cerebellum;	.	0.42092	0.09558	0.64123826	83.97617363	2150.67182	8.52624	1q31.1		0.2864	0.1825	0.3937	0.1078	0.2925	0.3561	0.2863	0.2384	0.2885	0.1911	0.3945	0.3576	0.1625	0.3024	0.3476	0.2984	rs12084264						
1	211533352	211533352	A	G	exonic	TRAF5		synonymous SNV	TRAF5:NM_001033910:exon5:c.A477G:p.A159A,TRAF5:NM_001319207:exon5:c.A510G:p.A170A,TRAF5:NM_004619:exon5:c.A477G:p.A159A,TRAF5:NM_145759:exon5:c.A477G:p.A159A	8.829041147296e-06	0.925326371922777	0.0746647990360753	TNF receptor associated factor 5	FUNCTION: Adapter protein and signal transducer that links members of the tumor necrosis factor receptor family to different signaling pathways by association with the receptor cytoplasmic domain and kinases. Mediates activation of NF-kappa-B and probably JNK. Seems to be involved in apoptosis. Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR. {ECO:0000269|PubMed:15121867}.; 	.	TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood.; 	smooth muscle;colon;parathyroid;skin;uterus;prostate;endometrium;larynx;testis;germinal center;brain;artery;unclassifiable (Anatomical System);lymph node;islets of Langerhans;blood;skeletal muscle;breast;pancreas;lung;epididymis;nasopharynx;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;aorta;	.	0.08401	0.16123	-0.045835247	50.34206181	216.64914	3.18150	1q32.3		0.0542	0.0248	0.0316	0.0304	0.0478	0.0617	0.0385	0.0743	0.0441	0.0239	0.0394	0.0728	0.0222	0.0412	0.0576	0.0591	rs2230779						
1	228033258	228033258	T	A	exonic	PRSS38		nonsynonymous SNV	PRSS38:NM_183062:exon4:c.T671A:p.I224N	0.0302666135927824	0.924653770873147	0.0450796155340703	protease, serine 38	.	.	.	.	.	.	.	1.422020658	94.93394669	1792.01767	7.81450	1q42.13		0.0384	0.0449	0.0248	0.0370	0.0453	0.0372	0.0412	0.0466	0.0368	0.0451	0.0227	0.0132	0.0229	0.0441	0.0328	0.0389	rs61741607						
2	54035508	54035508	G	C	exonic	ERLEC1		nonsynonymous SNV	ERLEC1:NM_001127397:exon9:c.G952C:p.V318L,ERLEC1:NM_015701:exon9:c.G952C:p.V318L	0.000679063416474332	0.995056886922254	0.00426404966127196	endoplasmic reticulum lectin 1	FUNCTION: Probable lectin that binds selectively to improperly folded lumenal proteins. May function in endoplasmic reticulum quality control and endoplasmic reticulum-associated degradation (ERAD) of both non-glycosylated proteins and glycoproteins. {ECO:0000269|PubMed:16531414, ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18502753}.; 	.	.	medulla oblongata;ovary;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;heart;cartilage;urinary;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;atrium;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;islets of Langerhans;bile duct;pancreas;lung;cornea;adrenal gland;placenta;hippocampus;kidney;stomach;cerebellum;	superior cervical ganglion;testis - interstitial;testis;globus pallidus;ciliary ganglion;skeletal muscle;	0.39225	0.10625	-0.690637458	15.12149092	592.52283	4.93296	2p16.2		0.0927	0.0711	0.1831	0.1872	0.0537	0.0708	0.0883	0.0980	0.0752	0.0668	0.1778	0.0861	0.1843	0.0529	0.0676	0.0733	rs2287345						
2	97493877	97493877	T	C	exonic	CNNM3		synonymous SNV	CNNM3:NM_199078:exon4:c.T1587C:p.F529F,CNNM3:NM_017623:exon5:c.T1731C:p.F577F	.	.	.	cyclin and CBS domain divalent metal cation transport mediator 3	FUNCTION: Probable metal transporter. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in heart and spleen. {ECO:0000269|PubMed:12657465}.; 	lymphoreticular;smooth muscle;ovary;salivary gland;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);heart;islets of Langerhans;adrenal cortex;pharynx;blood;lens;skeletal muscle;bile duct;breast;lung;placenta;macula lutea;visual apparatus;liver;spleen;kidney;mammary gland;stomach;cerebellum;thymus;	superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;	0.25818	0.10796	.	.	61.42965	1.59706	2q11.2		0.1449	0.7410	0.0850	0.1541	0.0692	0.0857	0.1297	0.0764	0.2665	0.7251	0.1112	0.1467	0.1315	0.0785	0.0796	0.1224	rs1320149						
2	99279812	99279812	C	A	exonic	MGAT4A		nonsynonymous SNV	MGAT4A:NM_001160154:exon1:c.G11T:p.S4I	0.0598161748111026	0.940037636876036	0.000146188312860848	mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A	FUNCTION: Glycosyltransferase that participates in the transfer of N-acetylglucosamine (GlcNAc) to the core mannose residues of N- linked glycans. Catalyzes the formation of the GlcNAcbeta1-4 branch on the GlcNAcbeta1-2Manalpha1-3 arm of the core structure of N-linked glycans. Essential for the production of tri- and tetra-antennary N-linked sugar chains. Involved in glucose transport by mediating SLC2A2/GLUT2 glycosylation, thereby controlling cell-surface expression of SLC2A2 in pancreatic beta cells.; 	.	TISSUE SPECIFICITY: Expressed in pancreas, spleen, thymus, prostate, small intestine, peripheral blood leukocytes and lymph node. Strongly overexpressed in choriocarcinoma cancer cell lines. Down-regulated in pancreatic cancer. {ECO:0000269|PubMed:10024668}.; 	unclassifiable (Anatomical System);cartilage;ovary;islets of Langerhans;colon;skeletal muscle;uterus;prostate;lung;placenta;testis;germinal center;kidney;brain;mammary gland;stomach;	superior cervical ganglion;ciliary ganglion;pons;	0.34187	0.12087	0.040529541	57.15380986	148.07025	2.65159	2q11.2		0.0295	0.0137	0.0768	0.0634	0.0461	0.0035	0.0425	0.0574	0.0180	0.0126	0.0788	0.0099	0.1022	0.0319	0.0053	0.0234	rs76878531						
2	116539941	116539941	A	G	exonic	DPP10		synonymous SNV	DPP10:NM_001321913:exon15:c.A735G:p.P245P,DPP10:NM_001321907:exon16:c.A1458G:p.P486P,DPP10:NM_001321909:exon16:c.A1380G:p.P460P,DPP10:NM_001004360:exon17:c.A1476G:p.P492P,DPP10:NM_001178034:exon17:c.A1509G:p.P503P,DPP10:NM_001178037:exon17:c.A1485G:p.P495P,DPP10:NM_001321908:exon17:c.A1407G:p.P469P,DPP10:NM_001321911:exon17:c.A1347G:p.P449P,DPP10:NM_001321914:exon17:c.A735G:p.P245P,DPP10:NM_020868:exon17:c.A1497G:p.P499P,DPP10:NM_001178036:exon18:c.A1347G:p.P449P,DPP10:NM_001321905:exon18:c.A1548G:p.P516P,DPP10:NM_001321906:exon18:c.A1476G:p.P492P,DPP10:NM_001321910:exon18:c.A1347G:p.P449P,DPP10:NM_001321912:exon18:c.A1347G:p.P449P	0.99998928551057	1.07144893960554e-05	3.39912349980731e-14	dipeptidyl peptidase like 10	FUNCTION: Promotes cell surface expression of the potassium channel KCND2 (PubMed:15454437). Modulates the activity and gating characteristics of the potassium channel KCND2 (PubMed:15454437). Has no dipeptidyl aminopeptidase activity (PubMed:12662155). {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15454437, ECO:0000269|PubMed:15671030}.; 	DISEASE: Asthma (ASTHMA) [MIM:600807]: The most common chronic disease affecting children and young adults. It is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. It is characterized by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi. {ECO:0000269|PubMed:14566338, ECO:0000269|PubMed:19237393}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in serum, T-cells and brain (at protein level). Expressed in brain, pancreas, spinal cord and adrenal glands. {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:14566338}.; 	unclassifiable (Anatomical System);uterus;lung;frontal lobe;hypothalamus;visual apparatus;testis;colon;kidney;brain;	globus pallidus;ciliary ganglion;	0.36675	0.14962	0.382138899	75.65463553	784.31527	5.53417	2q14.1		0.0004	0	8.702e-05	0.0044	0.0006	0	0.0011	6.064e-05	0.0002	0	0	0	0.0019	0.0009	0	0	rs137879246						
2	120078778	120078778	T	C	exonic	C2orf76		nonsynonymous SNV	C2orf76:NM_001322330:exon3:c.A136G:p.I46V,C2orf76:NM_001322331:exon3:c.A136G:p.I46V,C2orf76:NM_001017927:exon4:c.A136G:p.I46V,C2orf76:NM_001322329:exon4:c.A136G:p.I46V	0.00333205633699219	0.609126325636586	0.387541618026422	chromosome 2 open reading frame 76	.	.	.	unclassifiable (Anatomical System);uterus;lung;heart;liver;testis;germinal center;skin;	.	.	0.05220	0.657836546	84.27105449	35.71966	1.07429	2q14.2		0.6640	0.8144	0.6129	0.4322	0.7503	0.6690	0.6567	0.6770	0.7008	0.8009	0.6337	0.6060	0.4597	0.7591	0.6608	0.6990	rs1132267						
2	121989489	121989489	G	A	exonic	TFCP2L1		synonymous SNV	TFCP2L1:NM_014553:exon13:c.C1254T:p.I418I	0.999192586615908	0.000807412112885351	1.27120695004053e-09	transcription factor CP2-like 1	FUNCTION: Transcriptional suppressor. May suppress UBP1-mediated transcriptional activation. Required for normal duct development in the salivary gland and kidney (By similarity). Modulates the placental expression of CYP11A1. {ECO:0000250, ECO:0000269|PubMed:10644752}.; 	.	TISSUE SPECIFICITY: Highly expressed in placental JEG-3 cells and very low levels of expression in non-steroidogenic cells. No expression was seen in adrenal NCI-H295A cells or in adrenal tissue. {ECO:0000269|PubMed:10644752}.; 	unclassifiable (Anatomical System);heart;lacrimal gland;islets of Langerhans;colon;blood;bone marrow;breast;prostate;lung;thyroid;placenta;liver;spleen;kidney;	superior cervical ganglion;ciliary ganglion;kidney;atrioventricular node;	0.12962	0.10362	-0.400392389	26.85185185	222.44013	3.22468	2q14.2		0.4446	0.1298	0.3657	0.3754	0.4915	0.5251	0.4481	0.3893	0.4027	0.1381	0.3720	0.4901	0.4090	0.4914	0.5309	0.4784	rs2304667						
2	160076309	160076309	A	G	exonic	TANC1		synonymous SNV	TANC1:NM_001350062:exon19:c.A3006G:p.A1002A,TANC1:NM_001350063:exon20:c.A3240G:p.A1080A,TANC1:NM_001145909:exon22:c.A3585G:p.A1195A,TANC1:NM_001350064:exon22:c.A3588G:p.A1196A,TANC1:NM_033394:exon22:c.A3609G:p.A1203A,TANC1:NM_001350065:exon23:c.A3588G:p.A1196A	0.140685896305883	0.859314101332731	2.36138515542615e-09	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1	FUNCTION: May be a scaffold component in the postsynaptic density. {ECO:0000250}.; 	.	.	ovary;colon;parathyroid;fovea centralis;skin;retina;uterus;prostate;whole body;cochlea;endometrium;larynx;thyroid;pituitary gland;testis;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;tongue;hypothalamus;pharynx;skeletal muscle;bile duct;breast;lung;placenta;macula lutea;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;aorta;peripheral nerve;	.	0.22070	0.09998	-1.262475058	5.266572305	1280.16491	6.73695	2q24.2		0.0588	0.2274	0.0209	0.2131	0.0496	0.0187	0.0547	0.0706	0.0897	0.2139	0.0191	0.0430	0.2126	0.0630	0.0185	0.0428	rs11903200						
2	160132089	160132089	T	G	exonic	WDSUB1		nonsynonymous SNV	WDSUB1:NM_001330279:exon3:c.A137C:p.K46T,WDSUB1:NM_001128212:exon4:c.A644C:p.K215T,WDSUB1:NM_001128213:exon4:c.A644C:p.K215T,WDSUB1:NM_001307994:exon4:c.A644C:p.K215T,WDSUB1:NM_001330274:exon4:c.A644C:p.K215T,WDSUB1:NM_001330277:exon4:c.A383C:p.K128T,WDSUB1:NM_001330278:exon4:c.A644C:p.K215T,WDSUB1:NM_001330280:exon4:c.A24C:p.Q8H,WDSUB1:NM_152528:exon4:c.A644C:p.K215T	1.37628007456398e-06	0.609907467007598	0.390091156712327	WD repeat, sterile alpha motif and U-box domain containing 1	.	.	.	ovary;colon;parathyroid;fovea centralis;skin;uterus;prostate;thyroid;pituitary gland;testis;brain;pineal gland;unclassifiable (Anatomical System);adrenal cortex;blood;pancreas;lung;adrenal gland;placenta;macula lutea;liver;spleen;kidney;stomach;aorta;	.	0.34775	0.20974	0.132352165	63.48785091	5889.69211	15.89756	2q24.2		0.1011	0.3982	0.0448	0.2002	0.0357	0.0473	0.0817	0.1460	0.1470	0.3785	0.0528	0.1291	0.2077	0.0461	0.0404	0.0713	rs16843852						
2	169995790	169995790	G	A	exonic	LRP2		synonymous SNV	LRP2:NM_004525:exon74:c.C13359T:p.S4453S	0.99999999999851	1.48993861047412e-12	3.65906499707677e-46	LDL receptor related protein 2	FUNCTION: Acts together with cubilin to mediate HDL endocytosis (By similarity). May participate in regulation of parathyroid- hormone and para-thyroid-hormone-related protein release. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Absorptive epithelia, including renal proximal tubules.; 	unclassifiable (Anatomical System);ovary;spinal cord;parathyroid;fovea centralis;choroid;lens;skeletal muscle;retina;breast;optic nerve;lung;epididymis;placenta;thyroid;macula lutea;iris;head and neck;kidney;mammary gland;brain;	dorsal root ganglion;superior cervical ganglion;thyroid;ciliary ganglion;atrioventricular node;kidney;pons;trigeminal ganglion;skeletal muscle;	0.64775	0.54233	3.324377969	99.4220335	2032.71856	8.29976	2q31.1		0.0006	0	0	0.0079	0	0	0	0	0.0004	0	0	0	0.0074	0	0	0	rs202161925						
2	216264021	216264021	T	G	exonic	FN1		nonsynonymous SNV	FN1:NM_001306129:exon21:c.A3307C:p.I1103L,FN1:NM_001306130:exon21:c.A3307C:p.I1103L,FN1:NM_001306131:exon21:c.A3307C:p.I1103L,FN1:NM_001306132:exon21:c.A3307C:p.I1103L,FN1:NM_002026:exon21:c.A3307C:p.I1103L,FN1:NM_212474:exon21:c.A3307C:p.I1103L,FN1:NM_212476:exon21:c.A3307C:p.I1103L,FN1:NM_212478:exon21:c.A3307C:p.I1103L,FN1:NM_212482:exon21:c.A3307C:p.I1103L	0.0644415382988527	0.935558461701147	2.07475663084699e-16	fibronectin 1	FUNCTION: Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization. Participates in the regulation of type I collagen deposition by osteoblasts.; 	DISEASE: Glomerulopathy with fibronectin deposits 2 (GFND2) [MIM:601894]: Genetically heterogeneous autosomal dominant disorder characterized clinically by proteinuria, microscopic hematuria, and hypertension that leads to end-stage renal failure in the second to fifth decade of life. {ECO:0000269|PubMed:18268355}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Plasma FN (soluble dimeric form) is secreted by hepatocytes. Cellular FN (dimeric or cross-linked multimeric forms), made by fibroblasts, epithelial and other cell types, is deposited as fibrils in the extracellular matrix. Ugl-Y1, Ugl-Y2 and Ugl-Y3 are found in urine. {ECO:0000269|PubMed:17614963, ECO:0000269|PubMed:3584091}.; 	ovary;colon;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;cochlea;thyroid;bone;amniotic fluid;brain;unclassifiable (Anatomical System);heart;cartilage;tongue;islets of Langerhans;spinal cord;lens;skeletal muscle;breast;pancreas;lung;cornea;epididymis;placenta;trabecular meshwork;macula lutea;visual apparatus;amnion;liver;alveolus;head and neck;mammary gland;aorta;	dorsal root ganglion;superior cervical ganglion;adipose tissue;olfactory bulb;smooth muscle;heart;fetal liver;lung;trachea;placenta;liver;ciliary ganglion;fetal lung;trigeminal ganglion;	0.92203	0.99216	-2.323170444	1.18542109	825.54252	5.63214	2q35		0.0036	0.0009	0	0.0493	0	2.997e-05	0.0011	0.0001	0.0032	0.0006	0.0012	0	0.0562	0	0	0.0010	rs13306364						
2	219903258	219903258	T	G	exonic	CFAP65		nonsynonymous SNV	CFAP65:NM_001278296:exon3:c.A1C:p.M1L,CFAP65:NM_152389:exon3:c.A1C:p.M1L,CFAP65:NM_001278295:exon4:c.A163C:p.M55L,CFAP65:NM_194302:exon4:c.A196C:p.M66L	.	.	.	cilia and flagella associated protein 65	.	.	.	.	.	0.07665	.	-1.85098044	2.040575607	.	.	2q35		0.6993	0.5650	0.6071	0.4350	0.8392	0.7697	0.7190	0.6442	0.6976	0.5656	0.6627	0.7053	0.4478	0.8307	0.7694	0.7383	rs6736922						
2	231248261	231248261	C	T	exonic	SP140L		nonsynonymous SNV	SP140L:NM_001308162:exon7:c.C599T:p.T200M,SP140L:NM_001308163:exon7:c.C599T:p.T200M,SP140L:NM_138402:exon8:c.C674T:p.T225M	6.06952429760381e-05	0.994353439525744	0.00558586523127967	SP140 nuclear body protein like	.	.	.	unclassifiable (Anatomical System);breast;prostate;lung;cartilage;testis;colon;amniotic fluid;blood;brain;bone marrow;	dorsal root ganglion;ciliary ganglion;atrioventricular node;	.	.	1.444070618	95.09318235	1226.98768	6.62017	2q37.1		0.2545	0.2149	0.2300	0.2146	0.2293	0.2077	0.2516	0.4678	0.1557	0.1628	0.1539	0.1589	0.1527	0.1637	0.1473	0.1967	rs28497362						
2	233659553	233659553	C	A	exonic	GIGYF2		nonsynonymous SNV	GIGYF2:NM_001103148:exon12:c.C1360A:p.P454T,GIGYF2:NM_001103146:exon13:c.C1378A:p.P460T,GIGYF2:NM_001103147:exon15:c.C1441A:p.P481T,GIGYF2:NM_015575:exon15:c.C1378A:p.P460T	0.99999999997935	2.06501034539141e-11	4.07829157222728e-28	GRB10 interacting GYF protein 2	FUNCTION: May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling, including IGF1 and insulin receptors. {ECO:0000269|PubMed:12771153}.; 	DISEASE: Parkinson disease 11 (PARK11) [MIM:607688]: A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:18358451}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.69759	0.11014	-1.146380093	6.334041047	981.73564	6.04956	2q37.1		0.0524	0.0067	0.0744	0.2291	0.0711	0.0238	0.0661	0.0805	0.0354	0.0078	0.0656	0.0298	0.2146	0.0720	0.0218	0.0418	rs2289912						
2	234474147	234474147	A	G	exonic	USP40		synonymous SNV	USP40:NM_018218:exon1:c.T90C:p.Y30Y	1.74474759846129e-14	0.764370205739466	0.235629794260516	ubiquitin specific peptidase 40	FUNCTION: May be catalytically inactive.; 	.	TISSUE SPECIFICITY: Broadly expressed. {ECO:0000269|PubMed:14715245}.; 	unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;muscle;colon;skin;retina;uterus;pancreas;prostate;lung;larynx;amnion;duodenum;testis;spleen;brain;mammary gland;bladder;stomach;	atrioventricular node;	0.06046	0.09101	0.501484965	79.67681057	7072.32994	18.02774	2q37.1																								
2	238427194	238427194	T	C	exonic	MLPH		nonsynonymous SNV	MLPH:NM_001042467:exon5:c.T458C:p.L153P,MLPH:NM_001281473:exon5:c.T458C:p.L153P,MLPH:NM_024101:exon5:c.T458C:p.L153P,MLPH:NM_001281474:exon6:c.T458C:p.L153P	0.00125354964830075	0.9969698425912	0.00177660776049879	melanophilin	FUNCTION: Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor protein MYO5A. {ECO:0000269|PubMed:12062444}.; 	DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;parathyroid;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;lens;skeletal muscle;bile duct;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;prostate;trachea;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.49203	0.18515	0.494191824	79.62373201	636.84728	5.07635	2q37.3		0.1664	0.3664	0.0690	0.0743	0.1615	0.1715	0.1416	0.1347	0.1977	0.3394	0.0728	0.0927	0.0754	0.1383	0.1540	0.1619	rs3751109						
3	39152345	39152345	G	A	exonic	TTC21A		nonsynonymous SNV	TTC21A:NM_001105513:exon4:c.G272A:p.R91Q,TTC21A:NM_145755:exon4:c.G272A:p.R91Q	2.120275914728e-16	0.772223306613905	0.227776693386095	tetratricopeptide repeat domain 21A	.	.	TISSUE SPECIFICITY: Strongly expressed in testis. {ECO:0000269|PubMed:12543795}.; 	unclassifiable (Anatomical System);medulla oblongata;lung;islets of Langerhans;thyroid;liver;testis;colon;substantia nigra;spleen;brain;skeletal muscle;	.	0.12049	0.09851	0.683343061	84.94928049	8323.31002	19.75354	3p22.2		0.2916	0.5201	0.2622	0.2374	0.2530	0.2765	0.3270	0.2796	0.3505	0.5116	0.2661	0.3477	0.2556	0.2696	0.2923	0.3259	rs1112438						
3	97607290	97607290	G	A	exonic	CRYBG3		synonymous SNV	CRYBG3:NM_153605:exon9:c.G7395A:p.P2465P	0.000473718112503729	0.999466396142981	5.98857445152075e-05	crystallin beta-gamma domain containing 3	FUNCTION: Isoform vlAKAP: Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA). {ECO:0000269|PubMed:25097019}.; 	.	.	myocardium;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;cochlea;larynx;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;hypothalamus;adrenal cortex;blood;lens;skeletal muscle;pancreas;lung;placenta;macula lutea;visual apparatus;liver;head and neck;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;thyroid;globus pallidus;testis;appendix;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;	.	.	.	.	3552.09662	11.51760	3q11.2		0.2719	0.1285	0.3268	0.1557	0.3400	0.3016	0.2857	0.2304	0.2501	0.1251	0.3067	0.2333	0.1532	0.3291	0.3106	0.2699	rs13065340						
3	129297223	129297223	C	G	exonic	PLXND1		synonymous SNV	PLXND1:NM_015103:exon9:c.G2295C:p.T765T	0.999989724505468	1.02754945324598e-05	5.14607321368707e-17	plexin D1	FUNCTION: Cell surface receptor for SEMA4A and for class 3 semaphorins, such as SEMA3A, SEMA3C and SEMA3E. Plays an important role in cell-cell signaling, and in regulating the migration of a wide spectrum of cell types. Regulates the migration of thymocytes in the medulla. Regulates endothelial cell migration. Plays an important role in ensuring the specificity of synapse formation. Required for normal development of the heart and vasculature (By similarity). Mediates anti-angiogenic signaling in response to SEMA3E. {ECO:0000250, ECO:0000269|PubMed:20385769}.; 	.	TISSUE SPECIFICITY: Detected at low levels in heart, placenta, lung, skeletal muscle, kidney, thymus and liver. Detected at very low levels in brain, colon, spleen, small intestine and peripheral blood leukocytes. {ECO:0000269|PubMed:12412018}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;cerebral cortex;endometrium;bone;thyroid;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;muscle;blood;lens;breast;pancreas;lung;epididymis;placenta;macula lutea;visual apparatus;liver;hypopharynx;alveolus;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;thymus;	placenta;	0.15642	0.12590	-1.306585655	4.883227176	2739.76702	9.86834	3q22.1		0.2579	0.1981	0.2933	0.4243	0.2852	0.2482	0.3166	0.2111	0.1894	0.1563	0.1778	0.2517	0.4080	0.1857	0.1855	0.1847	rs1110168						
3	149459413	149459413	C	T	exonic	COMMD2		synonymous SNV	COMMD2:NM_016094:exon5:c.G495A:p.L165L	3.65344719758037e-07	0.105660219089619	0.894339415565662	COMM domain containing 2	FUNCTION: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). {ECO:0000269|PubMed:15799966, ECO:0000305|PubMed:21778237}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15799966}.; 	.	.	0.18300	0.10788	0.281220278	71.07808445	1969.53174	8.17837	3q25.1		0.1433	0.5301	0.1547	0.2486	0.0523	0.0796	0.1156	0.1322	0.2111	0.5238	0.1595	0.1167	0.2460	0.0550	0.0745	0.1010	rs11549572						
3	183432983	183432983	C	T	exonic	YEATS2		synonymous SNV	YEATS2:NM_001351369:exon2:c.C33T:p.T11T,YEATS2:NM_001351370:exon2:c.C33T:p.T11T,YEATS2:NM_001351371:exon2:c.C33T:p.T11T,YEATS2:NM_018023:exon2:c.C33T:p.T11T	0.999977828893892	2.21711061079428e-05	3.34975296171863e-16	YEATS domain containing 2	FUNCTION: Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. {ECO:0000269|PubMed:19103755}.; 	.	.	myocardium;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;larynx;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;heart;muscle;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;visual apparatus;head and neck;aorta;stomach;peripheral nerve;	.	0.11833	0.10042	-1.076610636	7.324840764	4718.02584	13.86609	3q27.1		0.1759	0.1554	0.3295	0.3089	0.1543	0.1525	0.1878	0.1130	0.1758	0.1644	0.2947	0.1490	0.3149	0.1590	0.1649	0.1786	rs3736535						
4	7857230	7857230	C	T	exonic	AFAP1		synonymous SNV	AFAP1:NM_001134647:exon4:c.G297A:p.P99P,AFAP1:NM_198595:exon4:c.G297A:p.P99P	0.376071779661091	0.623909220708965	1.89996299440042e-05	actin filament associated protein 1	FUNCTION: Can cross-link actin filaments into both network and bundle structures (By similarity). May modulate changes in actin filament integrity and induce lamellipodia formation. May function as an adapter molecule that links other proteins, such as SRC and PKC to the actin cytoskeleton. Seems to play a role in the development and progression of prostate adenocarcinoma by regulating cell-matrix adhesions and migration in the cancer cells. {ECO:0000250, ECO:0000269|PubMed:15485829}.; 	.	TISSUE SPECIFICITY: Low expression in normal breast epithelial cell line MCF-10A and in tumorigenic breast cancer cell lines MCF- 7, T-47D and ZR-75-1. Highly expressed in the invasive breast cancer cell lines MDA-MB-231 and MDA-MB-435. Overexpressed in prostate carcinoma. {ECO:0000269|PubMed:17520695, ECO:0000269|PubMed:17885682}.; 	medulla oblongata;ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;pharynx;blood;skeletal muscle;breast;pancreas;lung;cornea;placenta;visual apparatus;hippocampus;liver;amnion;head and neck;cervix;kidney;mammary gland;stomach;aorta;cerebellum;	trigeminal ganglion;	0.14735	.	-1.964136947	1.840056617	1928.06896	8.08165	4p16.1		0.3248	0.0939	0.1904	0.0707	0.4131	0.4421	0.3322	0.1825	0.3133	0.0984	0.2339	0.4139	0.0667	0.4164	0.4403	0.3612	rs61742221						
4	56847483	56847483	C	T	exonic	CEP135		nonsynonymous SNV	CEP135:NM_025009:exon13:c.C1717T:p.L573F	4.85411343707254e-17	0.972516179714832	0.0274838202851676	centrosomal protein 135kDa	FUNCTION: Centrosomal protein involved in centriole biogenesis. Acts as a scaffolding protein during early centriole biogenesis. Also required for centriole-centriole cohesion during interphase by acting as a platform protein for CEP250 at the centriole. {ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:18851962}.; 	DISEASE: Microcephaly 8, primary, autosomal recessive (MCPH8) [MIM:614673]: A disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. Despite this marked reduction in size, the gyral pattern is relatively well preserved, with no major abnormality in cortical architecture. Affected individuals are mentally retarded. Primary microcephaly is further defined by the absence of other syndromic features or significant neurological deficits due to degenerative brain disorder. {ECO:0000269|PubMed:22521416}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);cartilage;heart;ovary;fovea centralis;vein;skin;skeletal muscle;breast;uterus;lung;cochlea;mesenchyma;bone;thyroid;placenta;macula lutea;liver;testis;head and neck;spleen;germinal center;peripheral nerve;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;temporal lobe;globus pallidus;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.65762	0.11694	0.433520496	77.34725171	248.14339	3.39550	4q12		0.0002	0	0	0.0007	0	0.0002	0.0011	0.0001	9.694e-05	0.0001	0	0	0.0006	0	6.666e-05	0	rs556101805						
4	57887150	57887150	C	T	exonic	POLR2B		synonymous SNV	POLR2B:NM_001303268:exon16:c.C2184T:p.R728R,POLR2B:NM_000938:exon17:c.C2409T:p.R803R,POLR2B:NM_001303269:exon18:c.C2388T:p.R796R	0.988161838424889	0.0118381615626829	1.24283822618506e-11	polymerase (RNA) II subunit B	FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Second largest component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Proposed to contribute to the polymerase catalytic activity and forms the polymerase active center together with the largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB2 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template (By similarity). {ECO:0000250, ECO:0000269|PubMed:9852112}.; 	.	.	smooth muscle;ovary;skin;retina;bone marrow;prostate;optic nerve;cochlea;endometrium;thyroid;germinal center;brain;tonsil;heart;cartilage;tongue;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;larynx;bone;testis;artery;unclassifiable (Anatomical System);lymph node;small intestine;lacrimal gland;islets of Langerhans;hypothalamus;bile duct;pancreas;lung;cornea;adrenal gland;placenta;hippocampus;head and neck;kidney;stomach;aorta;thymus;	testis - interstitial;subthalamic nucleus;testis;pons;parietal lobe;cingulate cortex;	0.35804	0.49283	-1.001120478	8.321538099	27.50599	0.88564	4q12		0.0632	0.0878	0.0360	0.0614	0.0864	0.0731	0.0716	0.0181	0.0756	0.0948	0.0430	0.0430	0.0462	0.0854	0.0691	0.0560	rs2271806						
4	68829109	68829109	C	T	exonic	TMPRSS11A		nonsynonymous SNV	TMPRSS11A:NM_001114387:exon1:c.G3A:p.M1I,TMPRSS11A:NM_182606:exon1:c.G3A:p.M1I	9.57132467628292e-11	0.274857516145361	0.725142483758925	transmembrane protease, serine 11A	FUNCTION: Probable serine protease which may play a role in cellular senescence. Overexpression inhibits cell growth and induce G1 cell cycle arrest.; 	.	TISSUE SPECIFICITY: Expressed in esophagus, liver, colon and lung. Down-regulated in esophagus cancers. {ECO:0000269|PubMed:10920976}.; 	unclassifiable (Anatomical System);skeletal muscle;	dorsal root ganglion;superior cervical ganglion;temporal lobe;globus pallidus;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skin;skeletal muscle;	0.12560	0.11808	0.354632714	74.58126917	629.97615	5.05852	4q13.2		0.2070	0.1355	0.4202	0.1716	0.2183	0.1832	0.2263	0.2118	0.1626	0.1304	0.3684	0.16	0.1669	0.2071	0.1586	0.1687	rs977728						
4	98893437	98893437	A	G	exonic	STPG2		synonymous SNV	STPG2:NM_174952:exon7:c.T927C:p.D309D	1.00566542470556e-12	0.0211995660002018	0.978800433998793	sperm tail PG-rich repeat containing 2	.	.	.	.	.	0.13597	.	1.221756288	93.21184242	5857.7505	15.87174	4q23		0.4589	0.3617	0.6120	0.2565	0.4784	0.4682	0.4678	0.4735	0.4275	0.3471	0.5622	0.4967	0.2823	0.4658	0.4684	0.4846	rs783960						
4	103225513	103225513	T	C	exonic	SLC39A8		synonymous SNV	SLC39A8:NM_001135148:exon5:c.A600G:p.G200G,SLC39A8:NM_022154:exon5:c.A801G:p.G267G,SLC39A8:NM_001135146:exon6:c.A801G:p.G267G,SLC39A8:NM_001135147:exon6:c.A801G:p.G267G	0.891567478844834	0.108205187958135	0.000227333197031165	solute carrier family 39 member 8	FUNCTION: Acts as a zinc-influx transporter. {ECO:0000269|PubMed:12504855}.; 	.	TISSUE SPECIFICITY: Expressed in thymus, placenta, lung, liver, pancreas and, to a lower extent, in spleen, testis, ovary, small intestine, colon, leukocyte, heart. Highest expression is observed in pancreas. {ECO:0000269|PubMed:12504855}.; 	smooth muscle;ovary;colon;parathyroid;skin;uterus;prostate;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;hypothalamus;blood;skeletal muscle;bile duct;breast;pancreas;lung;nasopharynx;placenta;liver;spleen;head and neck;cervix;kidney;mammary gland;	superior cervical ganglion;trachea;salivary gland;placenta;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.15315	0.12750	0.17280645	65.75843359	320.26955	3.80273	4q24		0.1754	0.0951	0.2264	0.1240	0.1660	0.1736	0.2002	0.2272	0.1465	0.0877	0.2007	0.1788	0.1268	0.1591	0.1745	0.1732	rs11097773						
4	119944611	119944611	G	T	exonic	SYNPO2		synonymous SNV	SYNPO2:NM_001128933:exon2:c.G132T:p.G44G,SYNPO2:NM_001128934:exon2:c.G132T:p.G44G,SYNPO2:NM_001286754:exon2:c.G39T:p.G13G,SYNPO2:NM_001286755:exon2:c.G132T:p.G44G,SYNPO2:NM_133477:exon2:c.G132T:p.G44G	0.737066032210172	0.262933086667439	8.8112238893063e-07	synaptopodin 2	FUNCTION: Has an actin-binding and actin-bundling activity. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Skeletal muscle specific. {ECO:0000269|PubMed:11297942}.; 	smooth muscle;ovary;developmental;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;atrium;whole body;endometrium;larynx;thyroid;testis;spinal ganglion;brain;unclassifiable (Anatomical System);cartilage;heart;tongue;spinal cord;blood;lens;skeletal muscle;breast;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;alveolus;liver;spleen;head and neck;kidney;stomach;	superior cervical ganglion;skeletal muscle;	0.25557	0.10741	-0.231522913	36.36470866	5388.5703	15.14623	4q26		0.4661	0.2279	0.5107	0.4637	0.4649	0.4827	0.4680	0.5194	0.4185	0.2324	0.4713	0.3733	0.4658	0.4808	0.5023	0.4611	rs1459058						
4	129012181	129012181	G	A	exonic	LARP1B		synonymous SNV	LARP1B:NM_001278604:exon6:c.G384A:p.R128R,LARP1B:NM_018078:exon6:c.G384A:p.R128R,LARP1B:NM_032239:exon6:c.G384A:p.R128R,LARP1B:NM_178043:exon6:c.G384A:p.R128R	2.24164431739323e-06	0.999953445426085	4.4312929597087e-05	La ribonucleoprotein domain family member 1B	.	.	.	medulla oblongata;colon;skin;bone marrow;prostate;whole body;frontal lobe;endometrium;thyroid;bone;testis;germinal center;artery;brain;unclassifiable (Anatomical System);lymph node;tongue;islets of Langerhans;skeletal muscle;breast;lung;placenta;visual apparatus;liver;head and neck;kidney;aorta;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;	0.65320	.	0.760574103	86.83062043	226.20479	3.24995	4q28.2		0.6678	0.6149	0.7210	0.5014	0.6043	0.6713	0.6958	0.7605	0.6254	0.6159	0.7005	0.6722	0.5068	0.6107	0.6421	0.6247	rs2306054						
4	129100643	129100643	G	A	exonic	LARP1B		nonsynonymous SNV	LARP1B:NM_001350531:exon12:c.G1139A:p.R380H,LARP1B:NM_018078:exon15:c.G1979A:p.R660H	2.24164431739323e-06	0.999953445426085	4.4312929597087e-05	La ribonucleoprotein domain family member 1B	.	.	.	medulla oblongata;colon;skin;bone marrow;prostate;whole body;frontal lobe;endometrium;thyroid;bone;testis;germinal center;artery;brain;unclassifiable (Anatomical System);lymph node;tongue;islets of Langerhans;skeletal muscle;breast;lung;placenta;visual apparatus;liver;head and neck;kidney;aorta;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;	0.65320	.	0.760574103	86.83062043	226.20479	3.24995	4q28.2		0.6468	0.3897	0.7120	0.4932	0.6042	0.6711	0.6850	0.7606	0.5616	0.3948	0.6758	0.6722	0.4988	0.6110	0.6415	0.6127	rs12645577						
4	134076153	134076153	T	C	exonic	PCDH10		synonymous SNV	PCDH10:NM_032961:exon3:c.T2772C:p.D924D	0.894430213447045	0.105568021181273	1.76537168218335e-06	protocadherin 10	FUNCTION: Potential calcium-dependent cell-adhesion protein.; 	.	TISSUE SPECIFICITY: Moderately expressed in all regions of the brain examined, as well as in testis and ovary, and low expression in all other tissues tested. {ECO:0000269|PubMed:11549318}.; 	unclassifiable (Anatomical System);smooth muscle;spinal cord;choroid;fovea centralis;lens;retina;breast;optic nerve;placenta;macula lutea;kidney;brain;	amygdala;whole brain;subthalamic nucleus;occipital lobe;medulla oblongata;heart;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;parietal lobe;	0.58985	0.10504	-1.240018202	5.461193678	95.22371	2.10590	4q28.3		0.0357	0.0455	0.1090	0.1821	0.0243	0.0103	0.0308	0.0090	0.0327	0.0414	0.0811	0.0066	0.1912	0.0206	0.0113	0.0316	rs2271171						
5	26988328	26988328	G	A	exonic	CDH9		nonsynonymous SNV	CDH9:NM_016279:exon2:c.C113T:p.A38V	0.992483590378092	0.00751635010891187	5.95129960300399e-08	cadherin 9	FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types.; 	.	.	kidney;	superior cervical ganglion;atrioventricular node;skeletal muscle;parietal lobe;	0.42489	0.09429	-0.376526807	28.10804435	3357.77748	11.10339	5p14.1		0.4350	0.6894	0.2374	0.1594	0.5868	0.5027	0.4568	0.2205	0.5442	0.6888	0.2847	0.4801	0.1510	0.5706	0.5157	0.4898	rs2288466						
5	33649028	33649028	C	G	exonic	ADAMTS12		nonsynonymous SNV	ADAMTS12:NM_001324512:exon9:c.G1378C:p.G460R,ADAMTS12:NM_030955:exon9:c.G1378C:p.G460R	1.53777100809711e-11	0.999347073456606	0.000652926528016208	ADAM metallopeptidase with thrombospondin type 1 motif 12	FUNCTION: Metalloprotease that may play a role in the degradation of COMP. Cleaves also alpha-2 macroglobulin and aggregan. Has anti-tumorigenic properties. {ECO:0000269|PubMed:16611630, ECO:0000269|PubMed:17895370, ECO:0000269|PubMed:18485748}.; 	.	TISSUE SPECIFICITY: Expressed in skeletal muscle and fat. Detected at significant levels in fetal lung. Widely expressed in gastric carcinomas and in cancer cells of diverse origin. {ECO:0000269|PubMed:11279086, ECO:0000269|PubMed:16611630}.; 	unclassifiable (Anatomical System);ovary;salivary gland;pharynx;colon;blood;breast;pancreas;prostate;whole body;lung;bone;visual apparatus;liver;testis;kidney;brain;bladder;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;cingulate cortex;	0.10893	0.12072	0.865222355	88.74734607	1284.68357	6.74639	5p13.3																								
5	40931237	40931237	C	T	exonic	C7		nonsynonymous SNV	C7:NM_000587:exon3:c.C134T:p.T45I	1.26145650921317e-11	0.50794029347847	0.492059706508915	complement component 7	FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor.; 	DISEASE: Complement component 7 deficiency (C7D) [MIM:610102]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. {ECO:0000269|PubMed:8871666, ECO:0000269|PubMed:9218625, ECO:0000269|PubMed:9856499}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);smooth muscle;cartilage;ovary;heart;salivary gland;urinary;colon;skeletal muscle;retina;uterus;prostate;lung;cerebral cortex;adrenal gland;nasopharynx;thyroid;placenta;liver;testis;spleen;kidney;spinal ganglion;tonsil;stomach;	uterus;pancreas;lymph node;ovary;adrenal gland;placenta;adrenal cortex;appendix;fetal lung;kidney;	0.47789	0.10803	-0.214928658	37.7388535	3835.00708	12.19075	5p13.1		0.0005	0.0001	0.0039	0.0009	0	7.631e-05	0	0.0004	0.0002	0.0001	0.0012	0	0	0	0.0002	0	rs78327832						
5	74055222	74055222	G	T	exonic	GFM2		nonsynonymous SNV	GFM2:NM_032380:exon4:c.C178A:p.H60N,GFM2:NM_170681:exon4:c.C178A:p.H60N,GFM2:NM_170691:exon4:c.C178A:p.H60N,GFM2:NM_001281302:exon5:c.C274A:p.H92N	1.22849095804363e-08	0.98475563345386	0.01524435426123	G elongation factor, mitochondrial 2	FUNCTION: Mitochondrial GTPase that mediates the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. Acts in collaboration with MRRF. GTP hydrolysis follows the ribosome disassembly and probably occurs on the ribosome large subunit. Not involved in the GTP-dependent ribosomal translocation step during translation elongation. {ECO:0000255|HAMAP-Rule:MF_03059, ECO:0000269|PubMed:19716793}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11735030}.; 	medulla oblongata;smooth muscle;ovary;skin;bone marrow;retina;prostate;optic nerve;cochlea;endometrium;thyroid;germinal center;bladder;brain;gall bladder;heart;cartilage;tongue;pineal body;blood;lens;skeletal muscle;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;colon;parathyroid;fovea centralis;choroid;vein;uterus;whole body;bone;pituitary gland;testis;pineal gland;unclassifiable (Anatomical System);lymph node;islets of Langerhans;hypothalamus;pancreas;lung;adrenal gland;nasopharynx;placenta;hippocampus;duodenum;head and neck;kidney;stomach;aorta;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.13615	.	1.155610133	92.59259259	7010.51659	17.84819	5q13.3		0.0047	0	0	0.0637	0	4.5e-05	0.0011	0.0008	0.0027	0	0	0	0.0489	0	0.0001	0.0010	rs77099085	368528	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
5	112889374	112889374	G	A	exonic	YTHDC2		nonsynonymous SNV	YTHDC2:NM_001345976:exon12:c.G1055A:p.S352N,YTHDC2:NM_001345975:exon13:c.G1469A:p.S490N,YTHDC2:NM_022828:exon14:c.G1955A:p.S652N	0.999999571704339	4.28295661406565e-07	2.23811354771163e-20	YTH domain containing 2	FUNCTION: Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed:26318451). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:26318451). {ECO:0000269|PubMed:26318451}.; 	.	.	ovary;salivary gland;sympathetic chain;intestine;colon;parathyroid;skin;uterus;prostate;whole body;cochlea;endometrium;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;muscle;pharynx;blood;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;hypopharynx;liver;spleen;head and neck;cervix;kidney;stomach;thymus;	amygdala;dorsal root ganglion;medulla oblongata;superior cervical ganglion;testis;globus pallidus;atrioventricular node;	0.41393	0.09698	-0.275617382	33.58693088	3059.0798	10.51775	5q22.2		0.2512	0.5848	0.5304	0.1980	0.1687	0.1845	0.1982	0.1805	0.3121	0.5846	0.4581	0.1026	0.2295	0.1592	0.1992	0.2378	rs10071816						
6	25916979	25916979	C	T	exonic	SLC17A2		synonymous SNV	SLC17A2:NM_001286123:exon7:c.G864A:p.L288L,SLC17A2:NM_001286125:exon7:c.G864A:p.L288L,SLC17A2:NM_005835:exon8:c.G864A:p.L288L	0.00466985446742192	0.988892709808855	0.00643743572372291	solute carrier family 17 member 2	FUNCTION: May be involved in actively transporting phosphate into cells via Na+ cotransport. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in the small intestine, kidney, spleen and testis. Not detected in fetal brain, bone marrow, and mammary gland. {ECO:0000269|PubMed:9149941}.; 	unclassifiable (Anatomical System);liver;spleen;gall bladder;	superior cervical ganglion;fetal liver;medulla oblongata;liver;globus pallidus;atrioventricular node;trigeminal ganglion;	0.11920	0.10391	0.218717575	68.27081859	73.55201	1.79289	6p22.2		0.4071	0.1809	0.4975	0.7119	0.4184	0.3876	0.3940	0.4016	0.3556	0.1789	0.4570	0.3675	0.7085	0.4103	0.3979	0.4112	rs1865760						
6	28264681	28264681	G	A	exonic	PGBD1		nonsynonymous SNV	PGBD1:NM_001184743:exon5:c.G731A:p.G244E,PGBD1:NM_032507:exon5:c.G731A:p.G244E	1.46735073363618e-05	0.960551754807593	0.039433571685071	piggyBac transposable element derived 1	.	.	.	unclassifiable (Anatomical System);heart;muscle;fovea centralis;choroid;lens;skin;retina;uterus;breast;optic nerve;lung;oesophagus;bone;macula lutea;liver;cervix;kidney;brain;stomach;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;cerebellum;	0.03039	0.10231	1.137205722	92.32719981	2687.18695	9.75354	6p22.1		0.0903	0.1096	0.1358	0.2965	0.0528	0.0497	0.0815	0.1182	0.0838	0.1132	0.1372	0.0662	0.3167	0.0538	0.0465	0.0735	rs3800324						ID=CM071919;CLASS=DP;MUT=ALT;GENE=PGBD1;STRAND=+;DNA=NM_032507.3:c.731G>A;PROT=NP_115896.1:p.G244E;DB=rs3800324;PHEN="Alzheimer_disease_late-onset_association_with";RANKSCORE=0.1
6	31583312	31583312	G	A	exonic	AIF1		nonsynonymous SNV	AIF1:NM_001623:exon2:c.G40A:p.G14R	0.0127986482867158	0.857938830785659	0.129262520927625	allograft inflammatory factor 1	FUNCTION: Actin-binding protein that enhances membrane ruffling and RAC activation. Enhances the actin-bundling activity of LCP1. Binds calcium. Plays a role in RAC signaling and in phagocytosis. May play a role in macrophage activation and function. Promotes the proliferation of vascular smooth muscle cells and of T- lymphocytes. Enhances lymphocyte migration. Plays a role in vascular inflammation. {ECO:0000269|PubMed:15117732, ECO:0000269|PubMed:16049345, ECO:0000269|PubMed:18699778}.; 	.	TISSUE SPECIFICITY: Detected in T-lymphocytes and peripheral blood mononuclear cells. {ECO:0000269|PubMed:16049345}.; 	uterus;lymph node;lung;placenta;blood;brain;aorta;bone marrow;	.	0.67340	.	0.147123112	64.11299835	770.95879	5.49385	6p21.33		0.0554	0.1970	0.0670	0.1417	0.0062	0.0229	0.0430	0.0654	0.0734	0.1882	0.0644	0.0298	0.1457	0.0043	0.0183	0.0439	rs2736182						
6	32784676	32784676	C	T	exonic	HLA-DOB		nonsynonymous SNV	HLA-DOB:NM_002120:exon1:c.G53A:p.R18Q	9.08751665004379e-05	0.552954446504831	0.446954678328669	major histocompatibility complex, class II, DO beta	FUNCTION: Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.; 	.	.	.	.	0.11913	0.12310	0.72761005	86.08162302	1166.25764	6.49652	6p21.32		0.0678	0.1649	0.0372	0.0466	0.0690	0.0547	0.0700	0.0960	0.0797	0.1718	0.0489	0.0530	0.0425	0.0616	0.0381	0.0573	rs2071554						
6	38800164	38800164	G	A	exonic	DNAH8		nonsynonymous SNV	DNAH8:NM_001206927:exon31:c.G4255A:p.E1419K	2.09466493164173e-37	0.999999999144842	8.55157874037014e-10	dynein axonemal heavy chain 8	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly (By similarity). {ECO:0000250}.; 	.	.	prostate;lung;hypothalamus;testis;germinal center;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.33816	0.09678	.	.	14314.45201	26.19227	6p21.2		0.1518	0.1503	0.1385	0.3584	0.1090	0.1290	0.1145	0.1657	0.1433	0.1572	0.1360	0.1258	0.3690	0.0982	0.1231	0.1293	rs9357283						
6	41895150	41895150	G	A	exonic	BYSL		nonsynonymous SNV	BYSL:NM_004053:exon2:c.G307A:p.E103K	0.0673214421779635	0.929745128857109	0.00293342896492708	bystin like	FUNCTION: Required for processing of 20S pre-rRNA precursor and biogenesis of 40S ribosomal subunits. May be required for trophinin-dependent regulation of cell adhesion during implantation of human embryos. {ECO:0000269|PubMed:17360433, ECO:0000269|PubMed:17381424}.; 	.	TISSUE SPECIFICITY: Found in the placenta from the sixth week of pregnancy. Was localized in the cytoplasm of the syncytiotrophoblast in the chorionic villi and in endometrial decidual cells at the uteroplacental interface. After week 10, the level decreased and then disappeared from placental villi.; 	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;oesophagus;endometrium;thyroid;bone;testis;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;muscle;lens;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;liver;duodenum;spleen;cervix;kidney;mammary gland;stomach;	skeletal muscle;	0.60341	0.15537	0.442818085	77.8544468	1256.33001	6.68385	6p21.1		0.1079	0.0146	0.0512	0.1659	0.1699	0.1180	0.1159	0.1098	0.0952	0.0162	0.0788	0.1026	0.1650	0.1706	0.1147	0.1283	rs2296916						
6	43969839	43969839	C	A	exonic	C6orf223		nonsynonymous SNV	C6orf223:NM_001171992:exon3:c.C301A:p.P101T	0.0204906742338502	0.747307931055855	0.232201394710294	chromosome 6 open reading frame 223	.	.	.	unclassifiable (Anatomical System);ovary;salivary gland;intestine;pharynx;colon;blood;fovea centralis;choroid;lens;skin;retina;optic nerve;lung;cornea;macula lutea;visual apparatus;liver;cervix;kidney;brain;mammary gland;stomach;	.	0.04575	.	1.550689283	95.62396792	872.70364	5.75071	6p21.1		0.0046	0	0.0030	0.0962	0	0	0.0096	0.0003	0.0030	0.0002	0	0	0.0549	0	0	0.0010	rs80169011						
6	45909364	45909364	C	T	exonic	CLIC5		nonsynonymous SNV	CLIC5:NM_001114086:exon4:c.G803A:p.R268Q,CLIC5:NM_001256023:exon4:c.G326A:p.R109Q,CLIC5:NM_016929:exon4:c.G326A:p.R109Q	0.00187685115916181	0.724933929762025	0.273189219078813	chloride intracellular channel 5	FUNCTION: Required for normal hearing (PubMed:24781754). It is necessary for the formation of stereocilia in the inner ear and normal development of the organ of Corti (By similarity). Can insert into membranes and form poorly selective ion channels that may also transport chloride ions. May play a role in the regulation of transepithelial ion absorption and secretion. Is required for the development and/or maintenance of the proper glomerular endothelial cell and podocyte architecture (PubMed:15184393, PubMed:18028448, PubMed:20335315). {ECO:0000250|UniProtKB:Q8BXK9, ECO:0000269|PubMed:15184393, ECO:0000269|PubMed:18028448, ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	DISEASE: Deafness, autosomal recessive, 103 (DFNB103) [MIM:616042]: A form of sensorineural deafness with onset in early childhood. Hearing impairment progresses from mild to severe or even profound before the second decade, and is accompanied by vestibular areflexia. {ECO:0000269|PubMed:24781754}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed in both fetal and adult human tissues (PubMed:24781754). Isoform 1 is expressed in renal glomeruli endothelial cells and podocytes (at protein level). {ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	unclassifiable (Anatomical System);ovary;spinal cord;colon;fovea centralis;choroid;lens;retina;uterus;lung;optic nerve;whole body;placenta;macula lutea;liver;testis;kidney;brain;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;kidney;trigeminal ganglion;skeletal muscle;	0.25637	0.09418	1.019682101	90.97664544	213.77513	3.15479	6p21.1		0.0013	0.0003	0.0016	0.0065	0.0032	0.0008	0.0011	0.0004	0.0018	0.0006	0.0024	0	0.0043	0.0026	0.0018	0.0051	rs117204561	588806	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Likely_benign	
6	51824680	51824680	G	A	exonic	PKHD1		synonymous SNV	PKHD1:NM_138694:exon36:c.C5896T:p.L1966L,PKHD1:NM_170724:exon36:c.C5896T:p.L1966L	2.88608936958615e-23	0.999999999976766	2.32335774448585e-11	polycystic kidney and hepatic disease 1 (autosomal recessive)	FUNCTION: May be required for correct bipolar cell division through the regulation of centrosome duplication and mitotic spindle assembly. May be a receptor protein that acts in collecting-duct and biliary differentiation. {ECO:0000269|PubMed:20554582}.; 	.	TISSUE SPECIFICITY: Predominantly expressed in fetal and adult kidney. In the kidney, it is found in the cortical and medullary collecting ducts. Also present in the adult pancreas, but at much lower levels. Detectable in fetal and adult liver. Rather indistinct signal in fetal brain. {ECO:0000269|PubMed:14978161, ECO:0000269|PubMed:15458427}.; 	unclassifiable (Anatomical System);liver;kidney;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;	0.08201	0.25544	0.37824847	75.51309271	3737.47294	11.94762	6p12.2		0.0324	0.1350	0.0166	0.1079	0.0619	0.0058	0.0331	0.0351	0.0508	0.1226	0.0191	0.0166	0.1100	0.0638	0.0037	0.0295	rs1266923	102308	Autosomal_recessive_polycystic_kidney_disease|not_specified|not_provided	MedGen:C0085548,OMIM:263200,Orphanet:ORPHA731,SNOMED_CT:28770003|MedGen:CN169374|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
6	70866609	70866609	C	T	exonic	COL19A1		synonymous SNV	COL19A1:NM_001858:exon34:c.C2286T:p.G762G	5.55032017757713e-17	0.999008905415671	0.000991094584329417	collagen type XIX alpha 1	FUNCTION: May act as a cross-bridge between fibrils and other extracellular matrix molecules. Involved in skeletal myogenesis in the developing esophagus. May play a role in organization of the pericellular matrix or the sphinteric smooth muscle. {ECO:0000269|PubMed:12788917}.; 	.	TISSUE SPECIFICITY: Localized to vascular, neuronal, mesenchymal, and some epithelial basement membrane zones in umbilical cord. {ECO:0000269|PubMed:12788917}.; 	lung;nasopharynx;testis;kidney;germinal center;skeletal muscle;retina;	cerebellum peduncles;globus pallidus;ciliary ganglion;	.	0.12613	-0.121287852	44.12007549	3154.15403	10.69128	6q13		0.4883	0.6671	0.4587	0.3229	0.4175	0.4804	0.4579	0.5388	0.4949	0.6524	0.4702	0.5567	0.3050	0.4088	0.4456	0.4632	rs2229799						
6	108233929	108233929	G	A	exonic	SEC63		synonymous SNV	SEC63:NM_007214:exon6:c.C564T:p.N188N	1.24261908060209e-05	0.999895027797944	9.254601125033e-05	SEC63 homolog, protein translocation regulator	FUNCTION: Required for integral membrane and secreted preprotein translocation across the endoplasmic reticulum membrane.; 	.	TISSUE SPECIFICITY: Widely expressed, with high levels in the liver. {ECO:0000269|PubMed:15133510}.; 	.	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	6q21		0.8589	0.9068	0.9097	0.7208	0.8310	0.8536	0.8522	0.8986	0.8638	0.9073	0.8852	0.8874	0.7379	0.8278	0.8588	0.8633	rs675117	101373	Polycystic_liver_disease_1|not_specified	MedGen:C0887850,OMIM:174050|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
6	121642844	121642844	C	A	exonic	TBC1D32		nonsynonymous SNV	TBC1D32:NM_152730:exon2:c.G252T:p.Q84H	1.35030437532423e-12	0.99912157643649	0.000878423562160185	TBC1 domain family member 32	FUNCTION: Required for high-level Shh responses in the developing neural tube. Together with CDK20, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to Shh signaling (By similarity). {ECO:0000250}.; 	.	.	.	.	0.07698	.	1.697582556	96.4319415	3597.81877	11.61312	6q22.31										6.461e-05	0.0002	0	0	0	0	0	0							
6	137338202	137338202	T	C	exonic	IL20RA		nonsynonymous SNV	IL20RA:NM_014432:exon2:c.A127G:p.I43V	0.00757531716048163	0.977001983699394	0.015422699140124	interleukin 20 receptor subunit alpha	FUNCTION: The IL20RA/IL20RB dimer is a receptor for IL19, IL20 and IL24. The IL20RA/IL10RB dimer is a receptor for IL26.; 	.	TISSUE SPECIFICITY: Widely expressed with highest levels in skin and testis and high levels in brain. Highly expressed in psoriatic skin. {ECO:0000269|PubMed:11163236, ECO:0000269|PubMed:14764663}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;larynx;pituitary gland;testis;brain;unclassifiable (Anatomical System);heart;islets of Langerhans;blood;lens;skeletal muscle;lung;placenta;macula lutea;liver;head and neck;kidney;	ciliary ganglion;atrioventricular node;	0.13796	0.11768	0.376678994	75.50719509	564.20193	4.82236	6q23.3		0.0249	0.0010	0.0019	0.0252	0	0.0004	0.0198	0.1650	0.0017	0.0006	0.0012	0	0.0197	0	0.0001	0.0133	rs191996643						
7	6452461	6452461	G	A	exonic	DAGLB		nonsynonymous SNV	DAGLB:NM_001142936:exon11:c.C1163T:p.A388V,DAGLB:NM_139179:exon13:c.C1550T:p.A517V	1.65016137668239e-06	0.96259511835654	0.0374032314820835	diacylglycerol lipase beta	FUNCTION: Catalyzes the hydrolysis of diacylglycerol (DAG) to 2- arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses. {ECO:0000269|PubMed:14610053}.; 	.	.	ovary;sympathetic chain;colon;parathyroid;choroid;skin;retina;bone marrow;uterus;prostate;endometrium;bone;thyroid;iris;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;blood;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;alveolus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;thymus;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	7p22.1		0.0660	0.0420	0.0368	0.1696	0.0297	0.0412	0.0492	0.1011	0.0238	0.0282	0.0119	0.0232	0.0903	0.0092	0.0180	0.0245	rs1133850						
7	20698270	20698270	A	G	exonic	ABCB5		nonsynonymous SNV	ABCB5:NM_001163942:exon5:c.A343G:p.K115E,ABCB5:NM_001163993:exon5:c.A343G:p.K115E,ABCB5:NM_178559:exon5:c.A343G:p.K115E,ABCB5:NM_001163941:exon14:c.A1678G:p.K560E	1.16623512959537e-23	0.0269929301328199	0.97300706986718	ATP binding cassette subfamily B member 5	FUNCTION: Drug efflux transporter present in a number of stem cells that acts as a regulator of cellular differentiation. Able to mediate efflux from cells of the rhodamine dye and of the therapeutic drug doxorubicin. Specifically present in limbal stem cells, where it plays a key role in corneal development and repair. {ECO:0000269|PubMed:12960149, ECO:0000269|PubMed:15205344, ECO:0000269|PubMed:15899824, ECO:0000269|PubMed:22306008}.; 	.	TISSUE SPECIFICITY: Expressed by CD133-expressing progenitor cells among epidermal melanocytes (at protein level). Widely expressed with specific expression in pigment cells. Highly expressed in several malignant tissues: highly expressed in clinical melanomas, with low expression in normal skin. In melanoma, marks malignant melanoma-initiating cells (MMIC), in which clinical virulence resides as a consequence of unlimited self-renewal capacity, resulting in inexorable tumor progression and metastasis. Also highly expressed in a number of leukemia cells. Expressed in basal limbal epithelium. {ECO:0000269|PubMed:12960149, ECO:0000269|PubMed:15760339, ECO:0000269|PubMed:22044138, ECO:0000269|PubMed:22675422, ECO:0000269|PubMed:22784549, ECO:0000269|PubMed:23770371, ECO:0000269|PubMed:24934811, ECO:0000269|PubMed:25030174}.; 	testis;mammary gland;skin;	dorsal root ganglion;ciliary ganglion;atrioventricular node;	0.14704	0.09307	4.176155702	99.69922151	9731.34505	21.45196	7p21.1		0.3368	0.5629	0.3098	0.2006	0.3812	0.3171	0.3535	0.3451	0.3966	0.5775	0.3461	0.3046	0.1952	0.3653	0.3288	0.3391	rs2301641						ID=CM1314561;CLASS=DP;MUT=ALT;GENE=ABCB5;STRAND=+;DNA=NM_001163941.1:c.1678A>G;PROT=NP_001157413.1:p.K560E;DB=rs2301641;PHEN="Melanoma_reduced_risk_association_with";RANKSCORE=0.11
7	30915262	30915263	CA	TG	exonic	MINDY4		nonframeshift substitution	MINDY4:NM_032222:exon15:c.1962_1963TG:p.M655V																7p14.3																		rs386711774						
7	42088222	42088222	T	C	exonic	GLI3		nonsynonymous SNV	GLI3:NM_000168:exon5:c.A547G:p.T183A	0.999994739435503	5.26056449062654e-06	6.00953250163151e-15	GLI family zinc finger 3	FUNCTION: Has a dual function as a transcriptional activator and a repressor of the sonic hedgehog (Shh) pathway, and plays a role in limb development. The full-length GLI3 form (GLI3FL) after phosphorylation and nuclear translocation, acts as an activator (GLI3A) while GLI3R, its C-terminally truncated form, acts as a repressor. A proper balance between the GLI3 activator and the repressor GLI3R, rather than the repressor gradient itself or the activator/repressor ratio gradient, specifies limb digit number and identity. In concert with TRPS1, plays a role in regulating the size of the zone of distal chondrocytes, in restricting the zone of PTHLH expression in distal cells and in activating chondrocyte proliferation. Binds to the minimal GLI-consensus sequence 5'-GGGTGGTC-3'. {ECO:0000269|PubMed:10693759, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:17764085}.; 	DISEASE: Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]: Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism. {ECO:0000269|PubMed:10441342, ECO:0000269|PubMed:12414818, ECO:0000269|PubMed:12794692, ECO:0000269|PubMed:9302279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pallister-Hall syndrome (PHS) [MIM:146510]: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial A1 (PAPA1) [MIM:174200]: A condition characterized by the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type A, the extra digit is well-formed and articulates with the fifth or a sixth metacarpal/metatarsal. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial B (PAPB) [MIM:174200]: A condition characterized by an extra digit in the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type B the extra digit is not well formed and is frequently in the form of a skin. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly preaxial 4 (POP4) [MIM:174700]: Preaxial polydactyly (i.e., polydactyly on the radial/tibial side of the hand/foot) covers a heterogeneous group of entities. In preaxial polydactyly type IV, the thumb shows only the mildest degree of duplication, and syndactyly of various degrees affects fingers 3 and 4. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Is expressed in a wide variety of normal adult tissues, including lung, colon, spleen, placenta, testis, and myometrium.; 	.	.	0.99640	0.10708	-1.310171316	4.83014862	2831.41391	10.04419	7p14.1		0.5630	0.8643	0.3428	0.5606	0.5964	0.5726	0.5673	0.4762	0.6540	0.8617	0.4173	0.4228	0.5442	0.5920	0.5841	0.5744	rs846266	252880	Polydactyly|Pallister-Hall_syndrome|Greig_cephalopolysyndactyly_syndrome|not_specified|not_provided	Human_Phenotype_Ontology:HP:0010442,MedGen:C0152427,OMIM:603596,Orphanet:ORPHA2913,SNOMED_CT:367506006|MedGen:C0265220,OMIM:146510,Orphanet:ORPHA672,SNOMED_CT:56677004|MedGen:C0265306,OMIM:175700,SNOMED_CT:32985001|MedGen:CN169374|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
7	93518486	93518486	C	T	exonic	TFPI2		synonymous SNV	TFPI2:NM_001271003:exon3:c.G288A:p.E96E,TFPI2:NM_001271004:exon3:c.G321A:p.E107E,TFPI2:NM_006528:exon3:c.G321A:p.E107E	0.237365841602754	0.730418481825753	0.0322156765714934	tissue factor pathway inhibitor 2	FUNCTION: May play a role in the regulation of plasmin-mediated matrix remodeling. Inhibits trypsin, plasmin, factor VIIa/tissue factor and weakly factor Xa. Has no effect on thrombin. {ECO:0000269|PubMed:7872799}.; 	.	TISSUE SPECIFICITY: Umbilical vein endothelial cells, liver, placenta, heart, pancreas, and maternal serum at advanced pregnancy.; 	ovary;salivary gland;intestine;colon;parathyroid;vein;skin;retina;uterus;prostate;whole body;endometrium;bone;brain;bladder;unclassifiable (Anatomical System);cartilage;islets of Langerhans;pharynx;blood;greater omentum;bile duct;breast;lung;cornea;trabecular meshwork;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;aorta;	smooth muscle;lung;heart;placenta;beta cell islets;appendix;trigeminal ganglion;	0.31619	0.17731	0.549415813	81.38122199	42.26702	1.23033	7q21.3		0.0566	0.1065	0.1102	0.1710	0.0301	0.0239	0.0541	0.0712	0.0534	0.1043	0.1134	0.0464	0.1400	0.0255	0.0182	0.0469	rs34489123						
8	17820714	17820714	A	T	exonic	PCM1		synonymous SNV	PCM1:NM_001315507:exon17:c.A2568T:p.L856L,PCM1:NM_001315508:exon17:c.A2571T:p.L857L,PCM1:NM_006197:exon17:c.A2568T:p.L856L	.	.	.	pericentriolar material 1	FUNCTION: Required for centrosome assembly and function. Essential for the correct localization of several centrosomal proteins including CEP250, CETN3, PCNT and NEK2. Required to anchor microtubules to the centrosome. Involved in the biogenesis of cilia. {ECO:0000269|PubMed:12403812, ECO:0000269|PubMed:15659651, ECO:0000269|PubMed:16943179, ECO:0000269|PubMed:20551181, ECO:0000269|PubMed:24121310}.; 	DISEASE: Note=A chromosomal aberration involving PCM1 is found in papillary thyroid carcinomas (PTCs). Translocation t(8;10)(p21.3;q11.2) with RET links the protein kinase domain of RET to the major portion of PCM1. {ECO:0000269|PubMed:10980597}.; DISEASE: Note=A chromosomal aberration involving PCM1 is found in a variety of hematological malignancies including atypical chronic myeloid leukemia (atypical CML) and T-cell lymphoma. Translocation t(8;9)(p22;p24) with JAK2 links the protein kinase domain of JAK2 to the major portion of PCM1.; 	TISSUE SPECIFICITY: Expressed in blood, bone marrow, breast, lymph node, ovary and thyroid. {ECO:0000269|PubMed:10980597, ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321, ECO:0000269|PubMed:16424865}.; 	myocardium;lymphoreticular;smooth muscle;ovary;skin;bone marrow;retina;prostate;frontal lobe;endometrium;cochlea;thyroid;amniotic fluid;germinal center;brain;amygdala;heart;cartilage;tongue;pharynx;blood;skeletal muscle;breast;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;colon;parathyroid;fovea centralis;uterus;whole body;larynx;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;adrenal gland;nasopharynx;placenta;head and neck;kidney;stomach;aorta;thymus;cerebellum;	testis - interstitial;superior cervical ganglion;occipital lobe;testis - seminiferous tubule;prefrontal cortex;testis;caudate nucleus;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;skeletal muscle;	0.52458	0.13544	-0.323627113	30.93300307	3402.14478	11.17265	8p22		0.1700	0.2937	0.1042	0.3704	0.1689	0.1489	0.1989	0.1225	0.2036	0.2893	0.1241	0.1060	0.3807	0.1483	0.1564	0.1670	rs6991775						
8	27277537	27277537	G	A	exonic	PTK2B		synonymous SNV	PTK2B:NM_173175:exon3:c.G330A:p.T110T,PTK2B:NM_173176:exon3:c.G330A:p.T110T,PTK2B:NM_004103:exon4:c.G330A:p.T110T,PTK2B:NM_173174:exon8:c.G330A:p.T110T	0.984520870569303	0.0154791294066865	2.40103565257946e-11	protein tyrosine kinase 2 beta	FUNCTION: Non-receptor protein-tyrosine kinase that regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading and bone remodeling. Plays a role in the regulation of the humoral immune response, and is required for normal levels of marginal B-cells in the spleen and normal migration of splenic B-cells. Required for normal macrophage polarization and migration towards sites of inflammation. Regulates cytoskeleton rearrangement and cell spreading in T- cells, and contributes to the regulation of T-cell responses. Promotes osteoclastic bone resorption; this requires both PTK2B/PYK2 and SRC. May inhibit differentiation and activity of osteoprogenitor cells. Functions in signaling downstream of integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCR), cytokine, chemokine and growth factor receptors, and mediates responses to cellular stress. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Promotes activation of NOS3. Regulates production of the cellular messenger cGMP. Promotes activation of the MAP kinase signaling cascade, including activation of MAPK1/ERK2, MAPK3/ERK1 and MAPK8/JNK1. Promotes activation of Rho family GTPases, such as RHOA and RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Acts as a scaffold, binding to both PDPK1 and SRC, thereby allowing SRC to phosphorylate PDPK1 at 'Tyr-9, 'Tyr-373', and 'Tyr-376'. Promotes phosphorylation of NMDA receptors by SRC family members, and thereby contributes to the regulation of NMDA receptor ion channel activity and intracellular Ca(2+) levels. May also regulate potassium ion transport by phosphorylation of potassium channel subunits. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ASAP1, NPHP1, KCNA2 and SHC1. Promotes phosphorylation of ASAP2, RHOU and PXN; this requires both SRC and PTK2/PYK2. {ECO:0000269|PubMed:10022920, ECO:0000269|PubMed:12771146, ECO:0000269|PubMed:12893833, ECO:0000269|PubMed:14585963, ECO:0000269|PubMed:15050747, ECO:0000269|PubMed:15166227, ECO:0000269|PubMed:17634955, ECO:0000269|PubMed:18086875, ECO:0000269|PubMed:18339875, ECO:0000269|PubMed:18587400, ECO:0000269|PubMed:18765415, ECO:0000269|PubMed:19086031, ECO:0000269|PubMed:19207108, ECO:0000269|PubMed:19244237, ECO:0000269|PubMed:19428251, ECO:0000269|PubMed:19648005, ECO:0000269|PubMed:19880522, ECO:0000269|PubMed:20001213, ECO:0000269|PubMed:20381867, ECO:0000269|PubMed:20521079, ECO:0000269|PubMed:21357692, ECO:0000269|PubMed:21533080, ECO:0000269|PubMed:7544443, ECO:0000269|PubMed:8670418, ECO:0000269|PubMed:8849729}.; 	DISEASE: Note=Aberrant PTK2B/PYK2 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. Elevated PTK2B/PYK2 expression is seen in gliomas, hepatocellular carcinoma, lung cancer and breast cancer.; 	TISSUE SPECIFICITY: Most abundant in the brain, with highest levels in amygdala and hippocampus. Low levels in kidney (at protein level). Also expressed in spleen and lymphocytes. {ECO:0000269|PubMed:7544443, ECO:0000269|PubMed:9545257}.; 	lymphoreticular;ovary;colon;skin;bone marrow;prostate;frontal lobe;cerebral cortex;endometrium;larynx;thyroid;testis;germinal center;brain;tonsil;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;lacrimal gland;nervous;blood;lens;pancreas;lung;nasopharynx;placenta;visual apparatus;hippocampus;liver;spleen;head and neck;stomach;cerebellum;thymus;	amygdala;superior cervical ganglion;subthalamic nucleus;occipital lobe;thalamus;medulla oblongata;cerebellum peduncles;temporal lobe;prefrontal cortex;globus pallidus;pons;parietal lobe;cingulate cortex;cerebellum;	0.34869	0.74272	-1.275066404	5.189903279	2387.00343	9.06613	8p21.2		0.3983	0.4254	0.2151	0.2721	0.3839	0.4073	0.3902	0.5451	0.3940	0.4257	0.2266	0.3344	0.3002	0.3931	0.3964	0.3937	rs1030526						
8	28321247	28321247	C	T	exonic	FBXO16		nonsynonymous SNV	FBXO16:NM_001258211:exon3:c.G188A:p.R63Q,FBXO16:NM_172366:exon4:c.G224A:p.R75Q	6.61703415087813e-07	0.454532249196479	0.545467089100105	F-box protein 16	FUNCTION: Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation.; 	.	TISSUE SPECIFICITY: Expressed in heart, spleen and colon. {ECO:0000269|PubMed:12243353}.; 	unclassifiable (Anatomical System);smooth muscle;islets of Langerhans;colon;parathyroid;skin;skeletal muscle;retina;bone marrow;prostate;lung;nasopharynx;liver;testis;kidney;brain;	.	0.04035	.	0.262810045	70.43524416	4498.3269	13.47336	8p21.1		0.0053	0.0007	0.0036	0.0292	0.0011	0.0035	0.0055	0.0056	0.0035	0.0007	0.0048	0.0099	0.0308	0.0003	0.0029	0.0010	rs3735726						
8	53537316	53537316	A	G	exonic	RB1CC1		synonymous SNV	RB1CC1:NM_001083617:exon23:c.T4659C:p.L1553L,RB1CC1:NM_014781:exon23:c.T4668C:p.L1556L	0.999999798846797	2.01153202805607e-07	4.28675107823123e-19	RB1 inducible coiled-coil 1	FUNCTION: Plays a role as a modulator of TGF-beta-signaling by restricting substrate specificity of RNF111. Involved in autophagy. Regulates early events but also late events of autophagosome formation through direct interaction with Atg16L1. Required for the formation of the autophagosome-like double- membrane structure that surrounds the Salmonella-containing vacuole (SCV) duting S.typhimurium infection and subsequent xenophagy. Autophagy positively regulates repair of DNA damage induced by ionizing radiation and negatively regulates apoptosis. Plays an indispensible role in fetal hematopoiesis and in the regulation of neuronal homeostasis (By similarity). Implicated in the regulation of RB1 expression. Functions as a DNA-binding transcription factor. Is a potent regulator of the RB1 pathway and a mediator that plays a crucial role in muscular differentiation. Expression is, thus, a prerequisite for myogenic differentiation. Inhibits PTK2/FAK1 and PTK2B/PYK2 activity and activation of downstream signaling pathways. {ECO:0000250, ECO:0000269|PubMed:10769033, ECO:0000269|PubMed:12095676, ECO:0000269|PubMed:12163359, ECO:0000269|PubMed:12221124, ECO:0000269|PubMed:14533007, ECO:0000269|PubMed:21775823, ECO:0000269|PubMed:23262492}.; 	.	TISSUE SPECIFICITY: Expression levels correlated closely with those of RB1 in cancer cell lines as well as in various normal human tissues. Abundantly expressed in human musculoskeletal and cultured osteosarcoma cells. {ECO:0000269|PubMed:11850849, ECO:0000269|PubMed:12163359}.; 	smooth muscle;ovary;colon;parathyroid;skin;retina;uterus;prostate;atrium;whole body;cochlea;endometrium;bone;thyroid;pituitary gland;testis;germinal center;brain;bladder;pineal gland;unclassifiable (Anatomical System);heart;urinary;blood;lens;skeletal muscle;breast;pancreas;lung;cornea;mesenchyma;placenta;liver;spleen;kidney;stomach;peripheral nerve;	amygdala;occipital lobe;subthalamic nucleus;medulla oblongata;testis - interstitial;superior cervical ganglion;temporal lobe;prefrontal cortex;globus pallidus;trigeminal ganglion;parietal lobe;cingulate cortex;	0.82038	0.21518	-1.587406381	3.113941967	234.10831	3.30711	8q11.23		0.2329	0.0893	0.4412	0.6546	0.1612	0.1676	0.2253	0.2505	0.1807	0.0876	0.3585	0.1556	0.6575	0.1701	0.1767	0.1814	rs1129660						
8	59508134	59508134	T	C	exonic	NSMAF		nonsynonymous SNV	NSMAF:NM_001144772:exon22:c.A1970G:p.Y657C,NSMAF:NM_003580:exon22:c.A1877G:p.Y626C	3.1837468420093e-08	0.999185679415122	0.00081428874740948	neutral sphingomyelinase activation associated factor	FUNCTION: Couples the p55 TNF-receptor (TNF-R55 / TNFR1) to neutral sphingomyelinase (N-SMASE). Specifically binds to the N- smase activation domain of TNF-R55. May regulate ceramide production by N-SMASE.; 	.	TISSUE SPECIFICITY: Ubiquitous.; 	lymphoreticular;smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;bone;iris;testis;germinal center;brain;bladder;gall bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;adrenal cortex;pharynx;blood;cerebrum;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;ciliary ganglion;trigeminal ganglion;	0.39382	0.12404	-0.130380821	44.03161123	1327.81547	6.84836	8q12.1		0.0321	0.0541	0.0572	0.1904	0.0048	0.0039	0.0364	0.0424	0.0288	0.0565	0.0549	0.0166	0.1739	0.0046	0.0024	0.0163	rs2228505						
8	90990479	90990479	C	G	exonic	NBN		nonsynonymous SNV	NBN:NM_002485:exon5:c.G553C:p.E185Q,NBN:NM_001024688:exon6:c.G307C:p.E103Q	1.74403595456629e-10	0.594331223102722	0.405668776722875	nibrin	FUNCTION: Component of the MRE11-RAD50-NBN (MRN complex) which plays a critical role in the cellular response to DNA damage and the maintenance of chromosome integrity. The complex is involved in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity, cell cycle checkpoint control and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11A. RAD50 may be required to bind DNA ends and hold them in close proximity. NBN modulate the DNA damage signal sensing by recruiting PI3/PI4-kinase family members ATM, ATR, and probably DNA-PKcs to the DNA damage sites and activating their functions. It can also recruit MRE11 and RAD50 to the proximity of DSBs by an interaction with the histone H2AX. NBN also functions in telomere length maintenance by generating the 3' overhang which serves as a primer for telomerase dependent telomere elongation. NBN is a major player in the control of intra-S-phase checkpoint and there is some evidence that NBN is involved in G1 and G2 checkpoints. The roles of NBS1/MRN encompass DNA damage sensor, signal transducer, and effector, which enable cells to maintain DNA integrity and genomic stability. Forms a complex with RBBP8 to link DNA double-strand break sensing to resection. Enhances AKT1 phosphorylation possibly by association with the mTORC2 complex. {ECO:0000269|PubMed:10888888, ECO:0000269|PubMed:15616588, ECO:0000269|PubMed:19759395, ECO:0000269|PubMed:23762398, ECO:0000269|PubMed:9705271}.; 	DISEASE: Nijmegen breakage syndrome (NBS) [MIM:251260]: A disorder characterized by chromosomal instability, radiation sensitivity, microcephaly, growth retardation, immunodeficiency and predisposition to cancer, particularly to lymphoid malignancies. {ECO:0000269|PubMed:9590180}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:14684699}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Aplastic anemia (AA) [MIM:609135]: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. It is characterized by peripheral pancytopenia and marrow hypoplasia. {ECO:0000269|PubMed:15338273}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; DISEASE: Note=Defects in NBN might play a role in the pathogenesis of childhood acute lymphoblastic leukemia (ALL). {ECO:0000269|PubMed:11325820}.; 	TISSUE SPECIFICITY: Ubiquitous. Expressed at high levels in testis.; 	ovary;umbilical cord;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;larynx;bone;thyroid;pituitary gland;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;blood;lens;skeletal muscle;breast;lung;placenta;macula lutea;liver;hypopharynx;head and neck;kidney;mammary gland;stomach;	amygdala;dorsal root ganglion;medulla oblongata;superior cervical ganglion;testis - interstitial;subthalamic nucleus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;parietal lobe;skeletal muscle;	0.84431	0.65315	1.644346333	96.16654871	2534.24314	9.39528	8q21.3		0.3453	0.2357	0.3451	0.4438	0.3549	0.3275	0.3664	0.4294	0.3143	0.2339	0.3434	0.3344	0.4289	0.3604	0.3334	0.3531	rs1805794	138615	Hereditary_cancer-predisposing_syndrome|Microcephaly,_normal_intelligence_and_immunodeficiency|not_specified	MedGen:C0027672,SNOMED_CT:699346009|MedGen:C0398791,OMIM:251260,Orphanet:ORPHA647,SNOMED_CT:234638009|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign	ID=CM034886;CLASS=DP;MUT=ALT;GENE=NBN;STRAND=-;DNA=NM_002485.4:c.553G>C;PROT=NP_002476.2:p.E185Q;DB=rs1805794;PHEN="Lung_cancer_association_with";RANKSCORE=0.1
8	120790304	120790304	T	C	exonic	TAF2		synonymous SNV	TAF2:NM_003184:exon18:c.A2319G:p.T773T	0.566087060043687	0.433912903830149	3.61261637586587e-08	TATA-box binding protein associated factor 2	FUNCTION: Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. TFIID is a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. It requires core promoter-specific cofactors for productive transcription stimulation. TAF2 stabilizes TFIID binding to core promoter. {ECO:0000269|PubMed:9418870, ECO:0000269|PubMed:9774672}.; 	.	TISSUE SPECIFICITY: Expressed in all tissues tested. {ECO:0000269|PubMed:9774672}.; 	.	.	0.41383	0.11900	-0.042196577	50.49539986	1043.41092	6.19966	8q24.12		0.5695	0.6779	0.6348	0.4361	0.5983	0.5905	0.5737	0.4295	0.5944	0.6645	0.6355	0.6060	0.4478	0.5805	0.5714	0.5754	rs1509348						
8	142154291	142154291	G	A	exonic	DENND3		nonsynonymous SNV	DENND3:NM_014957:exon5:c.G428A:p.S143N	0.0171730327867355	0.982825328346388	1.63886687613821e-06	DENN domain containing 3	FUNCTION: Guanine nucleotide exchange factor (GEF) activating RAB12. Promotes the exchange of GDP to GTP, converting inactive GDP-bound RAB12 into its active GTP-bound form. Thereby, may play a role in protein transport from recycling endosomes to lysosomes regulating, for instance, the degradation of the transferrin receptor. {ECO:0000269|PubMed:20937701}.; 	.	.	smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;cerebral cortex;bone;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;lacrimal gland;islets of Langerhans;blood;lens;skeletal muscle;pancreas;lung;placenta;macula lutea;liver;alveolus;amnion;spleen;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;skeletal muscle;	0.09826	0.08644	-0.564052047	19.0552017	1817.59938	7.86039	8q24.3		0.1886	0.5091	0.2180	0.4769	0.1459	0.1003	0.1718	0.1903	0.2385	0.4971	0.1890	0.1233	0.4994	0.1377	0.0944	0.1487	rs307761						
9	6984236	6984236	G	A	exonic	KDM4C		nonsynonymous SNV	KDM4C:NM_001304340:exon9:c.G643A:p.D215N,KDM4C:NM_001146695:exon10:c.G1186A:p.D396N,KDM4C:NM_001146696:exon10:c.G1252A:p.D418N,KDM4C:NM_001304339:exon10:c.G1186A:p.D396N,KDM4C:NM_015061:exon10:c.G1186A:p.D396N	0.000758734602622751	0.999235107356564	6.15804081338881e-06	lysine demethylase 4C	FUNCTION: Histone demethylase that specifically demethylates 'Lys- 9' and 'Lys-36' residues of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-4', H3 'Lys-27' nor H4 'Lys-20'. Demethylates trimethylated H3 'Lys-9' and H3 'Lys-36' residue, while it has no activity on mono- and dimethylated residues. Demethylation of Lys residue generates formaldehyde and succinate. {ECO:0000269|PubMed:16603238}.; 	.	TISSUE SPECIFICITY: Overexpressed in several esophageal squamous cell carcinomas (ESCs). {ECO:0000269|PubMed:10987278}.; 	.	.	0.70659	.	-0.343575389	29.62373201	5314.03953	15.06707	9p24.1		0.2737	0.2047	0.3738	0.4142	0.1919	0.2163	0.2406	0.4402	0.2242	0.2142	0.3457	0.1767	0.3967	0.1924	0.2125	0.2311	rs2296067						ID=CM091846;CLASS=DP;MUT=ALT;GENE=KDM4C;STRAND=+;DNA=NM_015061.4:c.1186G>A;PROT=NP_055876.2:p.D396N;DB=rs2296067;PHEN="Upper_aerodigestive_tract_cancer_association_with";RANKSCORE=0.1
9	101056122	101056122	T	C	exonic	GABBR2		nonsynonymous SNV	GABBR2:NM_005458:exon18:c.A2605G:p.T869A	0.999790262521872	0.000209737468490762	9.63726054104311e-12	gamma-aminobutyric acid type B receptor subunit 2	FUNCTION: Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2. Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase, stimulates phospholipase A2, activates potassium channels, inactivates voltage-dependent calcium-channels and modulates inositol phospholipid hydrolysis. Plays a critical role in the fine-tuning of inhibitory synaptic transmission. Pre-synaptic GABA receptor inhibits neurotransmitter release by down-regulating high-voltage activated calcium channels, whereas postsynaptic GABA receptor decreases neuronal excitability by activating a prominent inwardly rectifying potassium (Kir) conductance that underlies the late inhibitory postsynaptic potentials. Not only implicated in synaptic inhibition but also in hippocampal long-term potentiation, slow wave sleep, muscle relaxation and antinociception. {ECO:0000269|PubMed:10328880, ECO:0000269|PubMed:18165688, ECO:0000269|PubMed:22660477, ECO:0000269|PubMed:24305054, ECO:0000269|PubMed:9872316}.; 	.	TISSUE SPECIFICITY: Highly expressed in brain, especially in cerebral cortex, thalamus, hippocampus, frontal, occipital and temporal lobe, occipital pole and cerebellum, followed by corpus callosum, caudate nucleus, spinal cord, amygdala and medulla. Weakly expressed in heart, testis and skeletal muscle. {ECO:0000269|PubMed:10087195, ECO:0000269|PubMed:10328880, ECO:0000269|PubMed:10727622}.; 	unclassifiable (Anatomical System);amygdala;ovary;hypothalamus;adrenal cortex;parathyroid;fovea centralis;skeletal muscle;optic nerve;whole body;lung;frontal lobe;placenta;macula lutea;visual apparatus;liver;spleen;pineal gland;brain;cerebellum;	amygdala;whole brain;thalamus;medulla oblongata;superior cervical ganglion;occipital lobe;cerebellum peduncles;hypothalamus;temporal lobe;pons;atrioventricular node;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;ciliary ganglion;parietal lobe;cingulate cortex;cerebellum;	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	9q22.33	ID=COSM3982633;OCCURENCE=1(thyroid)	0.1938	0.3843	0.1943	0.1520	0.1967	0.1732	0.1751	0.1789	0.2425	0.3917	0.2249	0.1457	0.1400	0.1952	0.1851	0.1765	rs10985765						
9	113191533	113191533	C	T	exonic	SVEP1		synonymous SNV	SVEP1:NM_153366:exon35:c.G5697A:p.V1899V	0.589007650495336	0.410992349504664	1.40850230409457e-16	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1	FUNCTION: May play a role in the cell attachment process. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Present in mesenchymal primary cultured cell lysates (at protein level). Highly expressed in placenta. Also expressed in marrow stromal cell. Weakly or not expressed in other tissues. {ECO:0000269|PubMed:11062057, ECO:0000269|PubMed:16206243}.; 	ovary;colon;parathyroid;choroid;skin;uterus;whole body;frontal lobe;cerebral cortex;larynx;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;skeletal muscle;breast;pancreas;lung;epididymis;nasopharynx;trabecular meshwork;placenta;visual apparatus;liver;hypopharynx;spleen;head and neck;kidney;mammary gland;	superior cervical ganglion;adipose tissue;placenta;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.75699	.	4.588666937	99.75819769	15016.94079	26.57856	9q31.3	ID=COSM3763522;OCCURENCE=1(large_intestine)	0.0604	0.0331	0.0362	0.0820	0.0378	0.0772	0.0349	0.0317	0.0302	0.0223	0.0239	0.0099	0.0377	0.0238	0.0370	0.0173	rs75212846						
10	16979606	16979606	G	T	exonic	CUBN		nonsynonymous SNV	CUBN:NM_001081:exon39:c.C5911A:p.P1971T	3.03432572949695e-28	0.9999999775831	2.24169003645547e-08	cubilin	FUNCTION: Cotransporter which plays a role in lipoprotein, vitamin and iron metabolism, by facilitating their uptake. Binds to ALB, MB, Kappa and lambda-light chains, TF, hemoglobin, GC, SCGB1A1, APOA1, high density lipoprotein, and the GIF-cobalamin complex. The binding of all ligands requires calcium. Serves as important transporter in several absorptive epithelia, including intestine, renal proximal tubules and embryonic yolk sac. Interaction with LRP2 mediates its trafficking throughout vesicles and facilitates the uptake of specific ligands like GC, hemoglobin, ALB, TF and SCGB1A1. Interaction with AMN controls its trafficking to the plasma membrane and facilitates endocytosis of ligands. May play an important role in the development of the peri-implantation embryo through internalization of APOA1 and cholesterol. Binds to LGALS3 at the maternal-fetal interface. {ECO:0000269|PubMed:10371504, ECO:0000269|PubMed:11606717, ECO:0000269|PubMed:11717447, ECO:0000269|PubMed:14576052, ECO:0000269|PubMed:9572993}.; 	DISEASE: Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100]: Due to selective malabsorption of vitamin B12. Defects in vitamin B12 absorption lead to impaired function of thymidine synthase. As a consequence DNA synthesis is interrupted. Rapidly dividing cells involved in erythropoiesis are particularly affected. {ECO:0000269|PubMed:10080186, ECO:0000269|PubMed:10887099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in kidney proximal tubule cells, placenta, visceral yolk-sac cells and in absorptive intestinal cells. Expressed in the epithelium of intestine and kidney.; 	.	.	0.16009	0.31630	1.257700362	93.49492805	6532.49526	17.00260	10p13		0.0582	0.0212	0.2952	0.1738	0.0207	0.0198	0.04	0.0264	0.0358	0.0213	0.2064	0.0298	0.1840	0.0192	0.0231	0.0297	rs2356590	309920	Megaloblastic_anemia	Human_Phenotype_Ontology:HP:0001889,MedGen:C0002888	criteria_provided,_single_submitter	Benign	
10	32141460	32141460	T	C	exonic	ARHGAP12		synonymous SNV	ARHGAP12:NM_001270699:exon3:c.A1014G:p.E338E,ARHGAP12:NM_001270697:exon5:c.A1014G:p.E338E,ARHGAP12:NM_001270698:exon5:c.A1014G:p.E338E,ARHGAP12:NM_001270695:exon6:c.A1155G:p.E385E,ARHGAP12:NM_001270696:exon6:c.A1155G:p.E385E,ARHGAP12:NM_018287:exon6:c.A1155G:p.E385E	0.00231777174845934	0.997652082001484	3.0146250056777e-05	Rho GTPase activating protein 12	FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}.; 	.	.	umbilical cord;ovary;salivary gland;intestine;colon;parathyroid;skin;bone marrow;uterus;prostate;optic nerve;frontal lobe;cochlea;endometrium;bone;thyroid;testis;germinal center;brain;pineal gland;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;adrenal cortex;pharynx;blood;breast;pancreas;lung;adrenal gland;trabecular meshwork;placenta;visual apparatus;liver;head and neck;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;skin;	0.59182	0.13510	-0.819281839	11.93677754	2139.4248	8.50730	10p11.22		0.2176	0.0799	0.2520	0.3841	0.1550	0.2078	0.2214	0.2576	0.1763	0.0835	0.2392	0.2219	0.3943	0.1602	0.2043	0.2026	rs2799021						
10	43678796	43678796	C	T	exonic	CSGALNACT2		nonsynonymous SNV	CSGALNACT2:NM_018590:exon8:c.C1435T:p.P479S	0.451240634927787	0.548498353594189	0.00026101147802408	chondroitin sulfate N-acetylgalactosaminyltransferase 2	FUNCTION: Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP- GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. {ECO:0000269|PubMed:12433924, ECO:0000269|PubMed:12446672}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:12433924, ECO:0000269|PubMed:12446672}.; 	.	.	0.32999	0.11194	-0.268115223	34.70747818	1778.77208	7.78907	10q11.21		0.2317	0.0652	0.1594	0.2321	0.3172	0.2761	0.2357	0.1731	0.2114	0.0663	0.1814	0.2682	0.2407	0.3080	0.2676	0.2597	rs2435381						
10	75527708	75527708	A	G	exonic	SEC24C		synonymous SNV	SEC24C:NM_198597:exon15:c.A2124G:p.T708T,SEC24C:NM_004922:exon16:c.A2124G:p.T708T	0.999992339582229	7.6604177564115e-06	1.50113043526113e-14	SEC24 homolog C, COPII coat complex component	FUNCTION: Component of the COPII coat, that covers ER-derived vesicles involved in transport from the endoplasmic reticulum to the Golgi apparatus. COPII acts in the cytoplasm to promote the transport of secretory, plasma membrane, and vacuolar proteins from the endoplasmic reticulum to the Golgi complex. {ECO:0000269|PubMed:10075675, ECO:0000269|PubMed:10214955, ECO:0000269|PubMed:10329445}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10329445}.; 	ovary;skin;bone marrow;retina;prostate;frontal lobe;endometrium;thyroid;iris;germinal center;bladder;brain;heart;cartilage;urinary;pharynx;blood;skeletal muscle;breast;epididymis;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;uterus;whole body;larynx;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;muscle;bile duct;pancreas;lung;nasopharynx;placenta;hypopharynx;head and neck;kidney;stomach;aorta;cerebellum;	testis - seminiferous tubule;	0.32022	0.09529	-0.968173992	8.982071243	215.09351	3.16444	10q22.2		0.1494	0.1455	0.1013	0.1295	0.1327	0.1460	0.1589	0.2162	0.1397	0.1428	0.1017	0.22	0.1344	0.1400	0.1391	0.1367	rs4746147						
10	116719543	116719543	G	A	exonic	TRUB1		nonsynonymous SNV	TRUB1:NM_139169:exon4:c.G500A:p.R167K	0.000523645293941091	0.885601090866897	0.113875263839162	TruB pseudouridine (psi) synthase family member 1	FUNCTION: May be responsible for synthesis of pseudouridine from uracil in transfer RNAs. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle and liver. Expressed at lower levels in lung, small intestine, kidney and spleen. {ECO:0000269|PubMed:12736709}.; 	medulla oblongata;ovary;colon;parathyroid;skin;retina;uterus;prostate;whole body;frontal lobe;cerebral cortex;endometrium;bone;testis;germinal center;brain;unclassifiable (Anatomical System);heart;islets of Langerhans;urinary;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;liver;spleen;kidney;thymus;	superior cervical ganglion;trigeminal ganglion;skin;	0.14422	0.19995	0.084621747	60.31493277	3037.63728	10.46800	10q25.3		0.4248	0.7460	0.2348	0.0390	0.4407	0.4586	0.4403	0.4131	0.5057	0.7474	0.2995	0.5430	0.0321	0.4364	0.4462	0.4622	rs7099565						
10	121579040	121579040	T	C	exonic	INPP5F		synonymous SNV	INPP5F:NM_001243194:exon1:c.T45C:p.F15F	0.00146883108535103	0.998530687106157	4.81808491868399e-07	inositol polyphosphate-5-phosphatase F	FUNCTION: Inositol 5-phosphatase which acts on phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. Hydrolyzes phosphatidylinositol 4,5- bisphosphate most effectively. Modulates AKT/GSK3B pathway by decreasing AKT and GSK3B phosphorylation. {ECO:0000269|PubMed:11274189, ECO:0000269|PubMed:17322895}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11274189}.; 	ovary;sympathetic chain;developmental;substantia nigra;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;endometrium;larynx;thyroid;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;heart;cerebellum cortex;nervous;islets of Langerhans;hypothalamus;spinal cord;blood;lens;skeletal muscle;lung;placenta;macula lutea;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	whole brain;amygdala;thalamus;occipital lobe;medulla oblongata;superior cervical ganglion;hypothalamus;temporal lobe;pons;caudate nucleus;subthalamic nucleus;prefrontal cortex;globus pallidus;cingulate cortex;parietal lobe;cerebellum;	0.16289	.	-0.793601146	12.57372022	536.63529	4.72241	10q26.11		0.1010	0.0104	0.0599	0.1987	0.0979	0.0594	0.0714	0.2817	0.0582	0.0103	0.0526	0.0497	0.1869	0.0929	0.0628	0.0857	rs17099318						
10	126691584	126691584	G	A	exonic	CTBP2		synonymous SNV	CTBP2:NM_022802:exon3:c.C1923T:p.I641I,CTBP2:NM_001321013:exon4:c.C303T:p.I101I,CTBP2:NM_001083914:exon5:c.C303T:p.I101I,CTBP2:NM_001290214:exon5:c.C303T:p.I101I,CTBP2:NM_001290215:exon5:c.C303T:p.I101I,CTBP2:NM_001321012:exon5:c.C303T:p.I101I,CTBP2:NM_001321014:exon5:c.C303T:p.I101I,CTBP2:NM_001329:exon5:c.C303T:p.I101I	0.655184958473335	0.344805061240602	9.98028606353552e-06	C-terminal binding protein 2	FUNCTION: Corepressor targeting diverse transcription regulators. Functions in brown adipose tissue (BAT) differentiation (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Highest levels in heart, skeletal muscle, and pancreas.; 	ovary;skin;retina;bone marrow;prostate;optic nerve;endometrium;thyroid;germinal center;bladder;brain;heart;cartilage;tongue;adrenal cortex;pharynx;blood;lens;breast;trabecular meshwork;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;vein;uterus;whole body;oesophagus;cerebral cortex;larynx;synovium;bone;testis;unclassifiable (Anatomical System);lacrimal gland;islets of Langerhans;hypothalamus;muscle;pancreas;lung;adrenal gland;placenta;head and neck;kidney;stomach;cerebellum;	superior cervical ganglion;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.48235	0.16121	0.371028035	74.95871668	17634.38171	27.99963	10q26.13		0.0008	0	0	0.0108	0	0	0.0011	6.057e-05	0.0006	0	0	0	0.0099	0	0.0002	0	rs145557678						
10	129911856	129911856	C	G	exonic	MKI67		nonsynonymous SNV	MKI67:NM_001145966:exon7:c.G411C:p.E137D,MKI67:NM_002417:exon8:c.G1491C:p.E497D	4.17035383841505e-16	0.998663438695794	0.00133656130420545	marker of proliferation Ki-67	FUNCTION: Thought to be required for maintaining cell proliferation.; 	.	.	.	.	0.62381	.	7.633856952	99.91153574	13447.4791	25.13173	10q26.2		0.1903	0.3242	0.2242	0.2808	0.1207	0.1718	0.1667	0.1386	0.2210	0.3242	0.2146	0.2450	0.2763	0.1317	0.1784	0.1782	rs11016076						
11	4159466	4159466	G	A	exonic	RRM1		synonymous SNV	RRM1:NM_001318065:exon13:c.G1218A:p.A406A,RRM1:NM_001330193:exon13:c.G1566A:p.A522A,RRM1:NM_001318064:exon18:c.G1941A:p.A647A,RRM1:NM_001033:exon19:c.G2232A:p.A744A	0.999994803572266	5.19642770538439e-06	2.88252150802573e-14	ribonucleotide reductase catalytic subunit M1	FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides.; 	.	.	ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;larynx;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;pharynx;blood;breast;pancreas;lung;mesenchyma;nasopharynx;placenta;visual apparatus;hippocampus;hypopharynx;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;thymus;	dorsal root ganglion;superior cervical ganglion;tumor;ciliary ganglion;	0.99050	0.35194	-0.644723694	16.52512385	49.59769	1.37845	11p15.4		0.8924	0.8140	0.8085	0.7412	0.8896	0.9267	0.9024	0.9423	0.8784	0.8104	0.8141	0.91	0.7435	0.8956	0.9311	0.8832	rs1042858						
11	8942942	8942942	C	T	exonic	C11orf16		nonsynonymous SNV	C11orf16:NM_020643:exon6:c.G1325A:p.R442Q	4.79365943685803e-06	0.40703931312569	0.592955893214873	chromosome 11 open reading frame 16	.	.	.	unclassifiable (Anatomical System);uterus;lung;endometrium;bone;testis;spleen;	superior cervical ganglion;appendix;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;parietal lobe;skeletal muscle;	0.19004	.	1.600244264	95.8893607	2404.61874	9.10571	11p15.4		0.3263	0.1242	0.2160	0.2275	0.3051	0.3633	0.3458	0.4409	0.2753	0.1265	0.2649	0.4167	0.2218	0.2960	0.3557	0.3497	rs2653601						
11	46917812	46917812	C	T	exonic	LRP4		nonsynonymous SNV	LRP4:NM_002334:exon9:c.G997A:p.G333R	0.10020880429216	0.899791195700632	7.20751508801609e-12	LDL receptor related protein 4	FUNCTION: Mediates SOST-dependent inhibition of bone formation. Functions as a specific facilitator of SOST-mediated inhibition of Wnt signaling. Plays a key role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between motor neuron and skeletal muscle. Directly binds AGRIN and recruits it to the MUSK signaling complex. Mediates the AGRIN- induced phosphorylation of MUSK, the kinase of the complex. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Alternatively, may be involved in the negative regulation of the canonical Wnt signaling pathway, being able to antagonize the LRP6-mediated activation of this pathway. More generally, has been proposed to function as a cell surface endocytic receptor binding and internalizing extracellular ligands for degradation by lysosomes. {ECO:0000269|PubMed:20381006, ECO:0000269|PubMed:21471202}.; 	DISEASE: Sclerosteosis 2 (SOST2) [MIM:614305]: A sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients. {ECO:0000269|PubMed:21471202, ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. {ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in bone; present in osteoblasts and osteocytes. No expression is observed in osteoclast. Expressed in several regions of the brain. {ECO:0000269|PubMed:21471202}.; 	.	.	0.57115	0.17022	-1.328641279	4.694503421	9909.87734	21.64220	11p11.2	ID=COSM147183;OCCURENCE=1(stomach)	0.0036	0.0193	0.0004	0.0268	0	3.009e-05	0.0033	0	0.0072	0.0203	0.0012	0	0.0247	0	6.662e-05	0.0041	rs61744209	196235	Syndactyly_Cenani_Lenz_type|Sclerosteosis_2|Myasthenic_syndrome,_congenital,_17|not_specified	MedGen:C1859309,OMIM:212780,Orphanet:ORPHA3258|MedGen:C3280402,OMIM:614305|MedGen:C4225377,OMIM:616304|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
11	73670645	73670645	T	C	exonic	DNAJB13		synonymous SNV	DNAJB13:NM_153614:exon3:c.T279C:p.H93H	0.121954826569755	0.872750328214636	0.00529484521560875	DnaJ heat shock protein family (Hsp40) member B13	FUNCTION: May be involved in inhibiting testis spermatogenesis apoptosis.; 	.	TISSUE SPECIFICITY: Specifically expressed in testis.; 	prostate;lung;cartilage;ovary;endometrium;placenta;urinary;liver;testis;parathyroid;	superior cervical ganglion;testis - seminiferous tubule;atrioventricular node;cerebellum;	0.13751	0.13274	0.396906589	76.30927105	2202.42808	8.64001	11q13.4		0.5102	0.8207	0.5527	0.4773	0.4876	0.4604	0.4967	0.5128	0.5712	0.8205	0.5407	0.4536	0.4696	0.4937	0.4632	0.5081	rs653263						
11	102649415	102649415	G	C	exonic	MMP10		nonsynonymous SNV	MMP10:NM_002425:exon4:c.C562G:p.P188A	1.98053112611486e-13	0.00817930161176316	0.991820698388039	matrix metallopeptidase 10	FUNCTION: Can degrade fibronectin, gelatins of type I, III, IV, and V; weakly collagens III, IV, and V. Activates procollagenase.; 	.	.	unclassifiable (Anatomical System);heart;ovary;tongue;colon;vein;skin;skeletal muscle;uterus;lung;endometrium;larynx;epididymis;alveolus;hypopharynx;duodenum;head and neck;	uterus corpus;testis - interstitial;	0.09719	0.63407	1.13538281	92.30360934	779.07324	5.52465	11q22.2		8.246e-06	0	0	0.0001	0	0	0	0									rs200519348						
11	120340060	120340060	A	T	exonic	ARHGEF12		nonsynonymous SNV	ARHGEF12:NM_001198665:exon29:c.A2861T:p.Y954F,ARHGEF12:NM_001301084:exon30:c.A2609T:p.Y870F,ARHGEF12:NM_015313:exon30:c.A2918T:p.Y973F	0.99999892582633	1.07417367028587e-06	8.6053136673698e-21	Rho guanine nucleotide exchange factor 12	FUNCTION: May play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13). Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as GTPase-activating protein (GAP) for GNA12 and GNA13. {ECO:0000269|PubMed:11094164}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is found in jejunum and testis.; 	myocardium;ovary;skin;retina;prostate;optic nerve;ganglion;frontal lobe;cochlea;endometrium;gum;thyroid;iris;germinal center;bladder;brain;heart;cartilage;tongue;pharynx;blood;lens;skeletal muscle;breast;trabecular meshwork;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;cerebral cortex;larynx;bone;testis;artery;pineal gland;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;bile duct;pancreas;lung;cornea;placenta;head and neck;kidney;stomach;aorta;	superior cervical ganglion;skeletal muscle;	0.47120	.	-0.323344668	30.9447983	743.24174	5.41202	11q23.3		0.0643	0.0093	0.0195	0.1508	0.0943	0.0554	0.0771	0.1062	0.0521	0.0107	0.0179	0.0563	0.1295	0.0933	0.0589	0.0713	rs2305013						
12	332362	332362	C	T	exonic	SLC6A13		synonymous SNV	SLC6A13:NM_001190997:exon10:c.G1074A:p.A358A,SLC6A13:NM_016615:exon12:c.G1350A:p.A450A	1.85726644531532e-08	0.641770503703225	0.35822947772411	solute carrier family 6 member 13	FUNCTION: Sodium-dependent GABA and taurine transporter. In presynaptic terminals, regulates GABA signaling termination through GABA uptake. May also be involved in beta-alanine transport. {ECO:0000269|PubMed:17502375, ECO:0000269|PubMed:22932902}.; 	.	TISSUE SPECIFICITY: Expressed in brain, kidney, lung, liver and testis. {ECO:0000269|PubMed:11824941, ECO:0000269|PubMed:17502375}.; 	unclassifiable (Anatomical System);optic nerve;lung;macula lutea;colon;fovea centralis;choroid;kidney;lens;brain;stomach;retina;	superior cervical ganglion;globus pallidus;kidney;trigeminal ganglion;skeletal muscle;	0.08446	0.14271	-0.527216948	20.8893607	398.80138	4.19401	12p13.33		0.1897	0.2337	0.1065	0.1718	0.1943	0.2021	0.1663	0.1787	0.2062	0.2360	0.1134	0.2450	0.1710	0.2111	0.1969	0.1929	rs2289954						
12	3728523	3728523	G	A	exonic	CRACR2A		nonsynonymous SNV	CRACR2A:NM_001144958:exon18:c.C1948T:p.R650W	.	.	.	calcium release activated channel regulator 2A	FUNCTION: Ca(2+)-binding protein that plays a key role in store- operated Ca(2+) entry (SOCE) in T-cells by regulating CRAC channel activation. Acts as a cytoplasmic calcium-sensor that facilitates the clustering of ORAI1 and STIM1 at the junctional regions between the plasma membrane and the endoplasmic reticulum upon low Ca(2+) concentration. It thereby regulates CRAC channel activation, including translocation and clustering of ORAI1 and STIM1. Upon increase of cytoplasmic Ca(2+) resulting from opening of CRAC channels, dissociates from ORAI1 and STIM1, thereby destabilizing the ORAI1-STIM1 complex. {ECO:0000269|PubMed:20418871}.; 	.	.	.	.	0.10919	0.10015	1.846456612	97.11606511	.	.	12p13.32		4.651e-05	0	0	0.0017	0	0	0	0									rs149484553						
12	10034237	10034237	C	T	exonic	KLRF2		nonsynonymous SNV	KLRF2:NM_001190765:exon1:c.C43T:p.R15C	.	.	.	killer cell lectin like receptor F2	FUNCTION: C-type lectin-like receptor involved in natural killer cell mediated cytotoxicity and cytokine secretion in keratinocytes via its interaction with CLEC2A. {ECO:0000269|PubMed:20194751}.; 	.	.	.	.	.	.	.	.	81.20681	1.90851	12p13.31		0.0013	0	0	0.0211	0	0.0008	0.0076	0.0011	0.0018	0	0	0	0.0284	0	0.0006	0	rs74614163						
12	21711167	21711167	A	G	exonic	GYS2		synonymous SNV	GYS2:NM_021957:exon11:c.T1389C:p.I463I	1.21631815172674e-14	0.146486871159475	0.853513128840512	glycogen synthase 2	FUNCTION: Transfers the glycosyl residue from UDP-Glc to the non- reducing end of alpha-1,4-glucan.; 	DISEASE: Glycogen storage disease 0 (GSD0) [MIM:240600]: A metabolic disorder characterized by fasting hypoglycemia presenting in infancy or early childhood, high blood ketones and low alanine and lactate concentrations. Although feeding relieves symptoms, it often results in postprandial hyperglycemia and hyperlactatemia. {ECO:0000269|PubMed:9691087}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);whole body;liver;spleen;kidney;	superior cervical ganglion;fetal liver;liver;	0.13195	0.57267	0.316000233	72.80018872	423.9852	4.29969	12p12.1		0.0042	0.0012	8.64e-05	0.0560	0	0	0.0011	0.0006	0.0031	0.0010	0	0	0.0518	0	6.661e-05	0.0020	rs146434233	316637	Hypoglycemia_with_deficiency_of_glycogen_synthetase_in_the_liver	MedGen:C1855861,OMIM:240600,Orphanet:ORPHA2089	criteria_provided,_single_submitter	Likely_benign	
12	56093667	56093667	G	A	exonic	ITGA7		synonymous SNV	ITGA7:NM_002206:exon5:c.C777T:p.L259L	1.80979797287063e-09	0.999585497375624	0.000414500814577502	integrin subunit alpha 7	FUNCTION: Integrin alpha-7/beta-1 is the primary laminin receptor on skeletal myoblasts and adult myofibers. During myogenic differentiation, it may induce changes in the shape and mobility of myoblasts, and facilitate their localization at laminin-rich sites of secondary fiber formation. It is involved in the maintenance of the myofibers cytoarchitecture as well as for their anchorage, viability and functional integrity. Isoform Alpha-7X2B and isoform Alpha-7X1B promote myoblast migration on laminin 1 and laminin 2/4, but isoform Alpha-7X1B is less active on laminin 1 (In vitro). Acts as Schwann cell receptor for laminin-2. Acts as a receptor of COMP and mediates its effect on vascular smooth muscle cells (VSMCs) maturation (By similarity). Required to promote contractile phenotype acquisition in differentiated airway smooth muscle (ASM) cells. {ECO:0000250, ECO:0000269|PubMed:10694445, ECO:0000269|PubMed:17641293, ECO:0000269|PubMed:9307969}.; 	DISEASE: Muscular dystrophy congenital due to integrin alpha-7 deficiency (MDCI) [MIM:613204]: A form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures. {ECO:0000269|PubMed:9590299}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoforms containing segment A are predominantly expressed in skeletal muscle. Isoforms containing segment B are abundantly expressed in skeletal muscle, moderately in cardiac muscle, small intestine, colon, ovary and prostate and weakly in lung and testes. Isoforms containing segment X2D are expressed at low levels in fetal and adult skeletal muscle and in cardiac muscle, but are not detected in myoblasts and myotubes. In muscle fibers isoforms containing segment A and B are expressed at myotendinous and neuromuscular junctions; isoforms containing segment C are expressed at neuromuscular junctions and at extrasynaptic sites. Isoforms containing segments X1 or X2 or, at low levels, X1X2 are expressed in fetal and adult skeletal muscle (myoblasts and myotubes) and cardiac muscle. {ECO:0000269|PubMed:8626012}.; 	myocardium;medulla oblongata;ovary;sympathetic chain;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;subthalamic nucleus;optic nerve;endometrium;cerebral cortex;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;muscle;lens;skeletal muscle;lung;placenta;macula lutea;hippocampus;liver;spleen;kidney;stomach;	amygdala;olfactory bulb;adipose tissue;tongue;spinal cord;ciliary ganglion;atrioventricular node;caudate nucleus;skeletal muscle;	0.26775	0.36635	0.170781634	65.34560038	592.64062	4.93434	12q13.2		0.0002	0	0	0.0035	0	0	0	0									rs200591528						
12	59284551	59284551	G	T	exonic	LRIG3		synonymous SNV	LRIG3:NM_001136051:exon4:c.C231A:p.L77L,LRIG3:NM_153377:exon4:c.C411A:p.L137L	0.426287752609207	0.573711717677384	5.29713408941538e-07	leucine-rich repeats and immunoglobulin like domains 3	FUNCTION: May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15203213}.; 	colon;bone marrow;uterus;prostate;whole body;cochlea;endometrium;larynx;gum;thyroid;bone;testis;brain;unclassifiable (Anatomical System);cartilage;islets of Langerhans;muscle;skeletal muscle;pancreas;lung;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;stomach;aorta;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.27502	0.12530	-0.723828344	14.26043878	171.34007	2.85415	12q14.1		0.0290	0.2507	0.0123	0.0372	0	0.0010	0.0188	0.0223	0.0722	0.2467	0.0119	0.0033	0.0359	0	0.0007	0.0061	rs11172799						
12	78334194	78334194	A	G	exonic	NAV3		synonymous SNV	NAV3:NM_001024383:exon2:c.A339G:p.L113L,NAV3:NM_014903:exon2:c.A339G:p.L113L	0.999999398861806	6.01138193965489e-07	4.23433117806603e-22	neuron navigator 3	FUNCTION: May regulate IL2 production by T-cells. May be involved in neuron regeneration. {ECO:0000269|PubMed:16166283}.; 	DISEASE: Note=A chromosomal aberration disrupting NAV3 has been found in patients with Sezary syndrome (PubMed:16166283). Translocation t(12;18)(q21;q21.2) (PubMed:16166283). {ECO:0000269|PubMed:16166283}.; 	TISSUE SPECIFICITY: Highly expressed in brain. Expressed at low levels in heart and placenta. Present in activated T-cells but not in resting T-cells (at protein level). Down-regulated in primary neuroblastoma. {ECO:0000269|PubMed:12062803, ECO:0000269|PubMed:12079279, ECO:0000269|PubMed:15158073, ECO:0000269|PubMed:16166283}.; 	ovary;parathyroid;fovea centralis;choroid;skin;retina;uterus;optic nerve;whole body;frontal lobe;cochlea;larynx;bone;testis;dura mater;brain;unclassifiable (Anatomical System);meninges;heart;cartilage;hypothalamus;lens;skeletal muscle;lung;pia mater;placenta;macula lutea;visual apparatus;hypopharynx;head and neck;stomach;	whole brain;amygdala;dorsal root ganglion;thalamus;medulla oblongata;superior cervical ganglion;occipital lobe;olfactory bulb;adipose tissue;cerebellum peduncles;hypothalamus;spinal cord;temporal lobe;atrioventricular node;caudate nucleus;pons;skeletal muscle;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;cerebellum;	0.80090	0.11717	-2.045202892	1.645435244	577.63321	4.87321	12q21.2		0.1211	0.0411	0.0620	0.2024	0.1145	0.1196	0.1228	0.1762	0.1028	0.0377	0.0742	0.1225	0.1996	0.1188	0.1245	0.1517	rs1382639						
12	80838175	80838175	C	T	exonic	PTPRQ		nonsynonymous SNV	PTPRQ:NM_001145026:exon1:c.C50T:p.T17I	.	.	.	protein tyrosine phosphatase, receptor type Q	FUNCTION: Phosphatidylinositol phosphatase required for auditory function. May act by regulating the level of phosphatidylinositol 4,5-bisphosphate (PIP2) level in the basal region of hair bundles. Can dephosphorylate a broad range of phosphatidylinositol phosphates, including phosphatidylinositol 3,4,5-trisphosphate and most phosphatidylinositol monophosphates and diphosphates. Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring. Has low tyrosine-protein phosphatase activity; however, the relevance of such activity in vivo is unclear. Plays an important role in adipogenesis of mesenchymal stem cells (MSCs). Regulates the phosphorylation state of AKT1 by suppressing the phosphatidylinositol 3,4,5-trisphosphate (PIP3) level in MSCs and preadipocyte cells. {ECO:0000269|PubMed:19351528}.; 	DISEASE: Deafness, autosomal recessive, 84A (DFNB84A) [MIM:613391]: A form of non-syndromic deafness characterized by progressive, sensorineural hearing loss and vestibular dysfunction. {ECO:0000269|PubMed:20346435, ECO:0000269|PubMed:20472657}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: In developing kidney, it localizes to the basal membrane of podocytes, beginning when podocyte progenitors can first be identified in the embryonic kidney (at protein level). Expressed in lung and kidney. {ECO:0000269|PubMed:12837292, ECO:0000269|PubMed:20346435}.; 	.	.	0.39566	0.10497	.	.	17963.04124	28.76351	12q21.31		0.0748	0.2498	0.0775	0.0391	0.0625	0.0200	0.0684	0.0891	0.0855	0.2322	0.1080	0.0132	0.0529	0.0314	0.0188	0.0502	rs60216135						
12	96387754	96387754	C	A	exonic	HAL		nonsynonymous SNV	HAL:NM_001258334:exon6:c.G434T:p.R145M,HAL:NM_002108:exon6:c.G434T:p.R145M	5.90868534733458e-17	0.0129668485976917	0.987033151402308	histidine ammonia-lyase	.	DISEASE: Histidinemia (HISTID) [MIM:235800]: Autosomal recessive disease characterized by increased histidine and histamine as well as decreased urocanic acid in body fluids. {ECO:0000269|PubMed:15806399}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);heart;pituitary gland;liver;spleen;blood;bone marrow;	fetal liver;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.51979	.	-0.659500046	16.07100731	149.14468	2.66223	12q23.1																								
12	109883374	109883374	T	C	exonic	MYO1H		nonsynonymous SNV	MYO1H:NM_001101421:exon30:c.T3002C:p.L1001P	2.91611360098295e-17	0.365254710934844	0.634745289065156	myosin IH	FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments (By similarity). {ECO:0000250}.; 	.	.	uterus;heart;bone;skin;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.18215	.	-0.547447733	19.99882048	2516.66481	9.35299	12q24.11		0.6584	0.9349	0.5237	0.5085	0.5542	0.6571	0.6496	0.7143	0.7167	0.9316	0.5800	0.6225	0.5253	0.5530	0.6656	0.6303	rs3825393						
12	110456175	110456175	A	G	exonic	ANKRD13A		synonymous SNV	ANKRD13A:NM_033121:exon5:c.A426G:p.P142P	0.350624808697698	0.649352032411301	2.31588910001787e-05	ankyrin repeat domain 13A	FUNCTION: Ubiquitin-binding protein that specifically recognizes and binds 'Lys-63'-linked ubiquitin. Does not bind 'Lys-48'-linked ubiquitin. Positively regulates the internalization of ligand- activated EGFR by binding to the Ub moiety of ubiquitinated EGFR at the cell membrane. {ECO:0000269|PubMed:22298428}.; 	.	.	smooth muscle;ovary;colon;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;hypothalamus;blood;breast;pancreas;lung;adrenal gland;trabecular meshwork;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;globus pallidus;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;cerebellum;	0.44603	0.09264	-0.600630256	18.06440198	499.55841	4.58943	12q24.11		0.1985	0.6163	0.1284	0.1321	0.1309	0.1534	0.2081	0.2276	0.2728	0.6034	0.1703	0.2033	0.1489	0.1292	0.1430	0.1493	rs2302689						
12	120148363	120148363	C	T	exonic	CIT		synonymous SNV	CIT:NM_007174:exon37:c.G4791A:p.T1597T,CIT:NM_001206999:exon38:c.G4917A:p.T1639T	0.999998739281467	1.26071853313229e-06	4.31141446977079e-24	citron rho-interacting serine/threonine kinase	FUNCTION: Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2. {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:21457715}.; 	.	.	ovary;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;optic nerve;frontal lobe;oesophagus;endometrium;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);heart;cartilage;nervous;tongue;blood;lens;skeletal muscle;bile duct;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;	amygdala;dorsal root ganglion;occipital lobe;thalamus;medulla oblongata;superior cervical ganglion;pons;caudate nucleus;atrioventricular node;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;cerebellum;	0.38018	0.37052	-2.354066177	1.144137768	351.69768	3.97507	12q24.23		0.0206	0.0495	0.0135	0.0225	0.0197	0.0192	0.0242	0.0126	0.0279	0.0465	0.0107	0	0.0204	0.0172	0.0227	0.0163	rs35490437						
13	22255230	22255230	C	A	exonic	FGF9		synonymous SNV	FGF9:NM_002010:exon2:c.C327A:p.G109G	0.910715910113492	0.0886141668494015	0.00066992303710623	fibroblast growth factor 9	FUNCTION: Plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. May have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors. {ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:8663044}.; 	DISEASE: Multiple synostoses syndrome 3 (SYNS3) [MIM:612961]: A bone disease characterized by multiple progressive joint fusions that commonly involve proximal interphalangeal, tarsal-carpal, humeroradial and cervical spine joints. Additional features can include progressive conductive deafness and facial dysmorphism. {ECO:0000269|PubMed:19589401}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Glial cells.; 	.	.	0.90259	0.31502	0.169169615	65.33380514	24.43081	0.80364	13q12.11		8.29e-06	0	0	0.0001	0	0	0	0									rs34748315						
13	34013847	34013847	G	C	exonic	STARD13		nonsynonymous SNV	STARD13:NM_001243476:exon5:c.C45G:p.N15K	1.84668647836473e-07	0.998409134245856	0.0015906810854965	StAR related lipid transfer domain containing 13	FUNCTION: GTPase-activating protein for RhoA, and perhaps for Cdc42. May be involved in regulation of cytoskeletal reorganization, cell proliferation and cell motility. Acts a tumor suppressor in hepatocellular carcinoma cells. {ECO:0000269|PubMed:14697242, ECO:0000269|PubMed:16217026}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed. Underexpressed in hepatocellular carcinoma cells and some breast cancer cell lines. {ECO:0000269|PubMed:12531887, ECO:0000269|PubMed:14697242}.; 	smooth muscle;sympathetic chain;colon;parathyroid;fovea centralis;choroid;vein;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;larynx;thyroid;bone;testis;spinal ganglion;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;adrenal cortex;lens;pancreas;lung;adrenal gland;placenta;macula lutea;liver;spleen;head and neck;kidney;stomach;	atrioventricular node;trigeminal ganglion;	0.55125	0.12968	-1.269658815	5.213493749	2449.56634	9.21182	13q13.2		0.4411	0.6946	0.4355	0.4899	0.5	0.4302	0.4015	0.4272	0.4924	0.6679	0.4678	0.3841	0.4802	0.3718	0.4288	0.4073	rs876133						
13	45515373	45515373	C	A	exonic	NUFIP1		nonsynonymous SNV	NUFIP1:NM_012345:exon10:c.G1456T:p.D486Y	3.91687077980072e-06	0.82085529897725	0.17914078415197	nuclear fragile X mental retardation protein interacting protein 1	FUNCTION: Binds RNA. {ECO:0000269|PubMed:10556305}.; 	.	TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon, peripheral blood leukocyte, heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas. {ECO:0000269|PubMed:10556305}.; 	.	.	0.55277	.	-0.200157416	39.11299835	50.37843	1.39556	13q14.12		8.25e-06	0	0	0	0	1.501e-05	0	0									rs770435388						
13	45515395	45515395	G	A	exonic	NUFIP1		synonymous SNV	NUFIP1:NM_012345:exon10:c.C1434T:p.I478I	3.91687077980072e-06	0.82085529897725	0.17914078415197	nuclear fragile X mental retardation protein interacting protein 1	FUNCTION: Binds RNA. {ECO:0000269|PubMed:10556305}.; 	.	TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon, peripheral blood leukocyte, heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas. {ECO:0000269|PubMed:10556305}.; 	.	.	0.55277	.	-0.200157416	39.11299835	50.37843	1.39556	13q14.12		0.0545	0.1406	0.0214	0.1975	0.0180	0.0339	0.0331	0.0475	0.0732	0.1426	0.0419	0.0232	0.2049	0.0226	0.0352	0.0377	rs17066360						
13	46154749	46154749	A	G	exonic	ERICH6B		nonsynonymous SNV	ERICH6B:NM_182542:exon6:c.T908C:p.L303P	.	.	.	glutamate rich 6B	.	.	.	.	.	.	.	2.710287147	98.93842887	.	.	13q14.13		0.0994	0.2723	0.0756	0.1710	0.0536	0.0483	0.0826	0.1146	0.1223	0.2679	0.0680	0.0364	0.1547	0.0558	0.0579	0.0694	rs11618506						
13	96638636	96638636	A	C	exonic	UGGT2		nonsynonymous SNV	UGGT2:NM_020121:exon9:c.T982G:p.S328A	1.01866409514518e-21	0.535349820839564	0.464650179160436	UDP-glucose glycoprotein glucosyltransferase 2	FUNCTION: Recognizes glycoproteins with minor folding defects. Reglucosylates single N-glycans near the misfolded part of the protein, thus providing quality control for protein folding in the endoplasmic reticulum. Reglucosylated proteins are recognized by calreticulin for recycling to the endoplasmic reticulum and refolding or degradation (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Higher levels in kidney, pancreas, heart, and skeletal muscle. {ECO:0000269|PubMed:10694380}.; 	.	.	0.06448	0.09703	1.282308148	93.6836518	5160.48386	14.76411	13q32.1		0.8599	0.7986	0.7506	0.9269	0.8805	0.8775	0.8852	0.8590	0.8563	0.7994	0.7914	0.82	0.9499	0.8861	0.8763	0.8648	rs816142						
13	102231676	102231676	G	T	exonic	ITGBL1		nonsynonymous SNV	ITGBL1:NM_001271754:exon4:c.G202T:p.A68S,ITGBL1:NM_001271755:exon4:c.G478T:p.A160S,ITGBL1:NM_001271756:exon4:c.G346T:p.A116S,ITGBL1:NM_004791:exon5:c.G625T:p.A209S	0.170877824203552	0.82854057783344	0.000581597963007633	integrin subunit beta like 1	.	.	TISSUE SPECIFICITY: Widely expressed in many tissues, but readily detectable only in aorta. {ECO:0000269|PubMed:10051402}.; 	.	.	0.17697	0.12974	0.64123826	83.97617363	1434.7471	7.07106	13q33.1	ID=COSM1188742;OCCURENCE=1(lung)	1.649e-05	0	0	0.0002	0	0	0	0									rs753390272						
13	103450973	103450973	T	C	exonic	KDELC1		synonymous SNV	KDELC1:NM_024089:exon1:c.A48G:p.P16P	6.41764150689518e-06	0.892032262402843	0.10796131995565	KDEL motif containing 1	.	.	.	.	.	0.13538	0.09760	-0.091746757	46.91554612	4102.6627	12.70963	13q33.1		0.0537	0.1312	0.0217	0.1015	0.0478	0.0425	0.0455	0.05	0.0754	0.1319	0.0239	0.0298	0.0969	0.0455	0.0519	0.0621	rs7994595						
13	114156093	114156093	C	T	exonic	TMCO3		synonymous SNV	TMCO3:NM_001349742:exon4:c.C651T:p.S217S,TMCO3:NM_001349743:exon4:c.C651T:p.S217S,TMCO3:NM_001349745:exon4:c.C651T:p.S217S,TMCO3:NM_001349741:exon5:c.C843T:p.S281S,TMCO3:NM_001349744:exon5:c.C843T:p.S281S,TMCO3:NM_001349746:exon5:c.C843T:p.S281S,TMCO3:NM_017905:exon5:c.C843T:p.S281S	6.68498405104448e-10	0.411660043201141	0.588339956130361	transmembrane and coiled-coil domains 3	FUNCTION: Probable Na+/H+ antiporter. {ECO:0000250}.; 	.	.	.	.	0.09724	0.09172	-0.10469683	45.64755839	1499.02081	7.20431	13q34		0.1700	0.3521	0.0944	0.2939	0.1376	0.1512	0.1744	0.1318	0.2098	0.3559	0.1110	0.2351	0.2966	0.1397	0.1401	0.1609	rs2260080						
14	23341951	23341951	C	T	exonic	LRP10		synonymous SNV	LRP10:NM_001329226:exon2:c.C39T:p.G13G,LRP10:NM_014045:exon2:c.C39T:p.G13G	0.000211411030039288	0.977954480363047	0.0218341086069136	LDL receptor related protein 10	FUNCTION: Probable receptor, which is involved in the internalization of lipophilic molecules and/or signal transduction. May be involved in the uptake of lipoprotein APOE in liver (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in blood leukocyte, lung, placenta, small intestine, liver, kidney, spleen, thymus, colon, skeletal muscle and heart. {ECO:0000269|PubMed:11123907}.; 	myocardium;medulla oblongata;ovary;salivary gland;colon;choroid;skin;retina;bone marrow;prostate;cerebral cortex;endometrium;larynx;bone;thyroid;pituitary gland;testis;amniotic fluid;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;lacrimal gland;islets of Langerhans;muscle;adrenal cortex;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;hippocampus;alveolus;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;placenta;kidney;trigeminal ganglion;whole blood;	0.19861	0.12057	-0.130380821	44.03161123	489.35059	4.55317	14q11.2	ID=COSM147742;OCCURENCE=1(stomach)	0.0272	0.1060	0.0096	0.0456	0.0436	0.0093	0.0375	0.0455	0.0477	0.1081	0.0131	0.0099	0.0598	0.0470	0.0151	0.0347	rs34294471						
14	25100282	25100282	A	G	exonic	GZMB		nonsynonymous SNV	GZMB:NM_001346011:exon5:c.T703C:p.Y235H,GZMB:NM_004131:exon5:c.T739C:p.Y247H	1.78750946382579e-06	0.431109670948733	0.568888541541804	granzyme B	FUNCTION: This enzyme is necessary for target cell lysis in cell- mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis.; 	.	.	unclassifiable (Anatomical System);ovary;salivary gland;intestine;pharynx;colon;blood;skin;breast;prostate;pancreas;lung;cornea;endometrium;thyroid;placenta;visual apparatus;alveolus;liver;spleen;kidney;brain;mammary gland;bladder;stomach;	whole blood;	0.04747	0.52613	0.305084559	72.22811984	2042.02554	8.32989	14q12		0.2460	0.3287	0.1469	0.2723	0.1881	0.2338	0.2445	0.3224	0.2498	0.3309	0.1499	0.2649	0.3012	0.1855	0.2188	0.2301	rs2236338						ID=CM033777;CLASS=DP;MUT=ALT;GENE=GZMB;STRAND=-;DNA=NM_004131.5:c.739T>C;PROT=NP_004122.2:p.Y247H;DB=rs2236338;PHEN="Apoptosis_unable_to_induce_association_with";RANKSCORE=0.1
14	65268100	65268100	A	G	exonic	SPTB		synonymous SNV	SPTB:NM_000347:exon6:c.T666C:p.F222F,SPTB:NM_001024858:exon6:c.T666C:p.F222F	0.999999747900015	2.52099984509224e-07	2.52004219585292e-22	spectrin beta, erythrocytic	FUNCTION: Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane.; 	DISEASE: Elliptocytosis 3 (EL3) [MIM:182870]: A Rhesus-unlinked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. {ECO:0000269|PubMed:1975598, ECO:0000269|PubMed:7883966, ECO:0000269|PubMed:8018926, ECO:0000269|PubMed:8226774}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 2 (SPH2) [MIM:616649]: An autosomal dominant form of hereditary spherocytosis, a group of hematologic disorders characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. Clinical manifestations include chronic hemolytic anemia, jaundice, and splenomegaly, with variable severity. {ECO:0000269|PubMed:19538529, ECO:0000269|PubMed:8102379}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;choroid;fovea centralis;skin;retina;uterus;prostate;optic nerve;frontal lobe;thyroid;bone;brain;unclassifiable (Anatomical System);heart;tongue;islets of Langerhans;muscle;lens;skeletal muscle;lung;macula lutea;liver;head and neck;spleen;peripheral nerve;cerebellum;	subthalamic nucleus;superior cervical ganglion;cerebellum peduncles;globus pallidus;atrioventricular node;caudate nucleus;pons;trigeminal ganglion;skeletal muscle;cerebellum;	0.31324	0.33019	-2.640400656	0.778485492	7634.17972	18.78025	14q23.3		0.0176	0.0455	0.0712	0.0243	0.0005	0.0030	0.0067	0.0257	0.0165	0.0433	0.0477	0.0166	0.0277	0.0003	0.0021	0.0092	rs17102119	255030	Elliptocytosis|not_specified|Spherocytosis,_Dominant|not_provided	Human_Phenotype_Ontology:HP:0004445,MedGen:C0427480|MedGen:CN169374|MedGen:CN239455|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
14	68260451	68260451	G	A	exonic	ZFYVE26		synonymous SNV	ZFYVE26:NM_015346:exon14:c.C2427T:p.G809G	1.03844572602961e-11	0.99999998403029	1.59593255760405e-08	zinc finger FYVE-type containing 26	FUNCTION: Phosphatidylinositol 3-phosphate-binding protein required for the abcission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abcission. May also be required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20208530}.; 	DISEASE: Spastic paraplegia 15, autosomal recessive (SPG15) [MIM:270700]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or mental retardation, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration. {ECO:0000269|PubMed:18394578, ECO:0000269|PubMed:19084844, ECO:0000269|PubMed:19805727}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Strongest expression in the adrenal gland, bone marrow, adult brain, fetal brain, lung, placenta, prostate, skeletal muscle, testis, thymus, and retina. Intermediate levels are detected in other structures, including the spinal cord. {ECO:0000269|PubMed:18394578}.; 	lymphoreticular;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;larynx;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;hypothalamus;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;duodenum;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;globus pallidus;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.08330	0.10527	-0.274087418	33.5928285	2850.19714	10.09609	14q24.1		0.0003	0	0	0.0044	0	0	0.0011	0	3.234e-05	0	0	0	0.0006	0	0	0	rs144063215	330206	not_specified|Spastic_Paraplegia,_Recessive	MedGen:CN169374|MedGen:CN239433	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	
14	93170993	93170993	C	T	exonic	LGMN		synonymous SNV	LGMN:NM_005606:exon13:c.G1251A:p.P417P,LGMN:NM_001008530:exon14:c.G1251A:p.P417P	0.00097489450100372	0.986740549161317	0.0122845563376795	legumain	FUNCTION: Has a strict specificity for hydrolysis of asparaginyl bonds. Can also cleave aspartyl bonds slowly, especially under acidic conditions. Required for normal lysosomal protein degradation in renal proximal tubules. Required for normal degradation of internalized EGFR. Plays a role in the regulation of cell proliferation via its role in EGFR degradation (By similarity). May be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system. {ECO:0000250, ECO:0000269|PubMed:23776206}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Particularly abundant in kidney, heart and placenta.; 	myocardium;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;iris;brain;gall bladder;heart;cartilage;tongue;pineal body;urinary;blood;lens;skeletal muscle;epididymis;visual apparatus;macula lutea;liver;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;whole body;larynx;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);small intestine;lacrimal gland;islets of Langerhans;pancreas;lung;mesenchyma;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	placenta;kidney;	0.18925	0.32479	-0.023789244	52.09365416	45.20813	1.29089	14q32.12		0.3563	0.2860	0.5892	0.0650	0.3908	0.4037	0.3485	0.1846	0.3578	0.2827	0.5120	0.4503	0.0660	0.3869	0.4141	0.3834	rs9791						
14	93199080	93199080	C	T	exonic	LGMN		nonsynonymous SNV	LGMN:NM_005606:exon2:c.G52A:p.V18I,LGMN:NM_001008530:exon3:c.G52A:p.V18I	0.00097489450100372	0.986740549161317	0.0122845563376795	legumain	FUNCTION: Has a strict specificity for hydrolysis of asparaginyl bonds. Can also cleave aspartyl bonds slowly, especially under acidic conditions. Required for normal lysosomal protein degradation in renal proximal tubules. Required for normal degradation of internalized EGFR. Plays a role in the regulation of cell proliferation via its role in EGFR degradation (By similarity). May be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system. {ECO:0000250, ECO:0000269|PubMed:23776206}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Particularly abundant in kidney, heart and placenta.; 	myocardium;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;iris;brain;gall bladder;heart;cartilage;tongue;pineal body;urinary;blood;lens;skeletal muscle;epididymis;visual apparatus;macula lutea;liver;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;whole body;larynx;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);small intestine;lacrimal gland;islets of Langerhans;pancreas;lung;mesenchyma;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	placenta;kidney;	0.18925	0.32479	-0.023789244	52.09365416	45.20813	1.29089	14q32.12		0.1934	0.2873	0.2760	0.2212	0.1848	0.1649	0.1905	0.1805	0.2111	0.2965	0.2410	0.1333	0.2361	0.1837	0.1660	0.1965	rs2236264						
15	72283488	72283488	G	A	exonic	MYO9A		nonsynonymous SNV	MYO9A:NM_006901:exon11:c.C1678T:p.R560C	0.999991725771394	8.2742286060295e-06	3.49330660269938e-24	myosin IXA	FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Regulates Rho activity in neurons, has a role in the regulation of neuronal morphology and function (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Found to be expressed in testis and placenta, and at lower levels in all the examined tissues with the exception of liver. Isoform 5 was found in leukocytes but not in brain, retina or testis. {ECO:0000269|PubMed:10409426}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;testis;germinal center;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;pharynx;blood;lens;skeletal muscle;breast;lung;cornea;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;testis;globus pallidus;ciliary ganglion;cingulate cortex;	0.76633	0.11338	-0.702137274	14.78532673	1190.95284	6.54335	15q23	ID=COSM1236086;OCCURENCE=1(haematopoietic_and_lymphoid_tissue)	0.0007	0	0	0.0090	0	3.171e-05	0	0	0.0004	0	0	0	0.0068	0	0	0.0010	rs184218886						
15	74622533	74622533	A	G	exonic	CCDC33		nonsynonymous SNV	CCDC33:NM_001287181:exon2:c.A73G:p.M25V,CCDC33:NM_182791:exon2:c.A73G:p.M25V,CCDC33:NM_025055:exon12:c.A1294G:p.M432V	8.63487200520327e-09	0.97529710922535	0.0247028821397779	coiled-coil domain containing 33	.	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;endometrium;spleen;	superior cervical ganglion;trigeminal ganglion;	0.08776	0.08702	1.139030387	92.34489266	4456.19559	13.38048	15q24.1		0.1111	0.0261	0.0422	0.2395	0.0754	0.0942	0.1325	0.2464	0.0738	0.0274	0.0597	0.1467	0.2138	0.0668	0.0853	0.0943	rs2277603						
15	74622549	74622549	G	T	exonic	CCDC33		nonsynonymous SNV	CCDC33:NM_001287181:exon2:c.G89T:p.R30L,CCDC33:NM_182791:exon2:c.G89T:p.R30L,CCDC33:NM_025055:exon12:c.G1310T:p.R437L	8.63487200520327e-09	0.97529710922535	0.0247028821397779	coiled-coil domain containing 33	.	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;endometrium;spleen;	superior cervical ganglion;trigeminal ganglion;	0.08776	0.08702	1.139030387	92.34489266	4456.19559	13.38048	15q24.1		0.0365	0.0073	0.0188	0.0967	0.0117	0.0379	0.0443	0.0379	0.0257	0.0067	0.0310	0.0430	0.0866	0.0095	0.0325	0.0368	rs2277604						
16	57762411	57762411	C	T	exonic	DRC7		nonsynonymous SNV	DRC7:NM_001289163:exon15:c.C2111T:p.A704V,DRC7:NM_032269:exon16:c.C2306T:p.A769V,DRC7:NM_001289162:exon17:c.C2306T:p.A769V	.	.	.	dynein regulatory complex subunit 7	FUNCTION: Key component of the nexin-dynein regulatory complex (N- DRC), essential for N-DRC integrity. Involved in the regulation of flagellar motility. {ECO:0000250|UniProtKB:A8JAM0}.; 	.	.	.	.	0.23416	0.10344	0.723780906	85.87520642	.	.	16q21		0.0002	9.885e-05	0	0.0009	0	4.607e-05	0.0011	0.0005	9.686e-05	0	0	0	0.0012	0	6.664e-05	0	rs373693140						
16	71609856	71609856	C	T	exonic	TAT		synonymous SNV	TAT:NM_000353:exon3:c.G309A:p.S103S	0.0214384440123944	0.975114738186389	0.00344681780121647	tyrosine aminotransferase	FUNCTION: Transaminase involved in tyrosine breakdown. Converts tyrosine to p-hydroxyphenylpyruvate. Can catalyze the reverse reaction, using glutamic acid, with 2-oxoglutarate as cosubstrate (in vitro). Has much lower affinity and transaminase activity towards phenylalanine. {ECO:0000269|PubMed:16640556, ECO:0000269|PubMed:7999802}.; 	DISEASE: Tyrosinemia 2 (TYRSN2) [MIM:276600]: An inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, and oculocutaneous manifestations. Typical features include palmoplantar keratosis, painful corneal ulcers, and mental retardation. {ECO:0000269|PubMed:1357662}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);breast;lung;liver;testis;mammary gland;skeletal muscle;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;liver;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.37643	0.70880	-0.558357437	19.54470394	674.69759	5.18783	16q22.2		0.0657	0.0989	0.0627	0.0040	0.0478	0.0669	0.0672	0.0815	0.0715	0.0982	0.0716	0.0767	0.0012	0.0621	0.0656	0.0735	rs78302875	255857	Hypertyrosinemia|not_specified	Human_Phenotype_Ontology:HP:0003231,MedGen:C1879362|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
17	11532835	11532835	A	G	exonic	DNAH9		synonymous SNV	DNAH9:NM_001372:exon7:c.A1452G:p.E484E	1.36586328854305e-35	0.999999244383913	7.55616087445322e-07	dynein axonemal heavy chain 9	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP.; 	.	.	unclassifiable (Anatomical System);uterus;lung;heart;hypothalamus;placenta;testis;brain;skin;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	17p12		0.3236	0.7243	0.2061	0.1451	0.3710	0.3015	0.3422	0.3159	0.4106	0.7120	0.2285	0.2815	0.1416	0.3587	0.2942	0.3272	rs9895535	390219	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
17	19644472	19644472	A	T	exonic	ALDH3A1		synonymous SNV	ALDH3A1:NM_001135168:exon5:c.T741A:p.P247P,ALDH3A1:NM_001330150:exon5:c.T522A:p.P174P,ALDH3A1:NM_000691:exon6:c.T741A:p.P247P,ALDH3A1:NM_001135167:exon6:c.T741A:p.P247P	1.32614029510281e-12	0.0129943681011167	0.987005631897557	aldehyde dehydrogenase 3 family member A1	FUNCTION: ALDHs play a major role in the detoxification of alcohol-derived acetaldehyde. They are involved in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation. This protein preferentially oxidizes aromatic aldehyde substrates. It may play a role in the oxidation of toxic aldehydes.; 	.	TISSUE SPECIFICITY: High levels in stomach, esophagus and lung; low level in the liver and kidney.; 	unclassifiable (Anatomical System);tongue;salivary gland;colon;fovea centralis;choroid;lens;skin;retina;uterus;pancreas;optic nerve;lung;endometrium;macula lutea;visual apparatus;testis;head and neck;cervix;kidney;brain;stomach;	superior cervical ganglion;lung;trachea;tongue;temporal lobe;	0.38989	.	0.113945049	62.14319415	3022.02935	10.43597	17p11.2		0.3549	0.1193	0.3676	0.3229	0.4144	0.3934	0.3201	0.3337	0.3262	0.1218	0.3640	0.27	0.2916	0.4266	0.4202	0.3951	rs2072330						
17	28612448	28612448	G	C	exonic	BLMH		synonymous SNV	BLMH:NM_000386:exon6:c.C603G:p.T201T	0.00956068971702177	0.988142630036378	0.00229668024660047	bleomycin hydrolase	FUNCTION: The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity. {ECO:0000250}.; 	.	.	smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;cerebral cortex;endometrium;bone;thyroid;pituitary gland;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;muscle;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;mesenchyma;placenta;macula lutea;visual apparatus;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;thymus;	superior cervical ganglion;	0.53505	0.38742	-0.093566408	46.7386176	1907.62332	8.04328	17q11.2		0.3046	0.2631	0.3595	0.1797	0.3376	0.3251	0.2720	0.2638	0.3043	0.2585	0.3577	0.2517	0.1654	0.3499	0.3316	0.3313	rs7342921						
17	34264859	34264859	A	G	exonic	LYZL6		synonymous SNV	LYZL6:NM_001199951:exon3:c.T201C:p.D67D,LYZL6:NM_020426:exon3:c.T201C:p.D67D	7.44688375794253e-05	0.305733992863965	0.694191538298456	lysozyme like 6	.	.	TISSUE SPECIFICITY: Expressed in testis and epididymis. {ECO:0000269|PubMed:16014814}.; 	medulla oblongata;lung;testis;	superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;testis;skeletal muscle;	0.08732	0.10009	0.393270925	76.04977589	1283.21856	6.74534	17q12		0.1278	0.2062	0.0730	0.1168	0.1150	0.1400	0.1427	0.0784	0.1529	0.1894	0.0990	0.1026	0.1006	0.1110	0.1530	0.1242	rs2280783						
17	79244802	79244802	T	C	exonic	SLC38A10		synonymous SNV	SLC38A10:NM_001037984:exon10:c.A1047G:p.T349T,SLC38A10:NM_138570:exon10:c.A1047G:p.T349T	4.09242180982345e-08	0.98655460568366	0.0134453533921224	solute carrier family 38 member 10	FUNCTION: Putative sodium-dependent amino acid/proton antiporter. {ECO:0000250}.; 	.	.	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;optic nerve;thyroid;bone;testis;brain;unclassifiable (Anatomical System);lymph node;cartilage;islets of Langerhans;muscle;lens;breast;lung;placenta;macula lutea;hippocampus;liver;cervix;head and neck;kidney;mammary gland;thymus;	thyroid;liver;	0.11386	0.09454	1.13164289	92.23873555	8935.42464	20.45812	17q25.3		0.3999	0.7528	0.3446	0.1593	0.4060	0.4239	0.4161	0.2426	0.5015	0.7464	0.3708	0.3841	0.1578	0.4141	0.4318	0.4115	rs2292184						
18	48327815	48327815	G	A	exonic	MRO		synonymous SNV	MRO:NM_001127176:exon5:c.C531T:p.A177A,MRO:NM_031939:exon6:c.C489T:p.A163A	0.000178042221372106	0.698824831115749	0.300997126662879	maestro	.	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11401430}.; 	unclassifiable (Anatomical System);medulla oblongata;lymph node;lung;iris;testis;kidney;skeletal muscle;	dorsal root ganglion;superior cervical ganglion;globus pallidus;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.05661	0.10002	0.284856336	71.40835103	6637.73489	17.24298	18q21.2		0.4941	0.2982	0.6710	0.3471	0.5207	0.4984	0.5210	0.5415	0.4416	0.3117	0.6331	0.4801	0.3619	0.5117	0.4946	0.4908	rs2276186						
18	66542006	66542006	G	T	exonic	CCDC102B		nonsynonymous SNV	CCDC102B:NM_024781:exon5:c.G1037T:p.C346F,CCDC102B:NM_001093729:exon7:c.G1037T:p.C346F	3.31193608462394e-09	0.304915311599463	0.695084685088601	coiled-coil domain containing 102B	.	.	.	unclassifiable (Anatomical System);lung;whole body;cartilage;islets of Langerhans;larynx;testis;spleen;head and neck;kidney;mammary gland;retina;	superior cervical ganglion;uterus corpus;skeletal muscle;	0.71689	0.08539	1.822581424	97.02170323	3864.66325	12.25371	18q22.1		0.1758	0.2870	0.2153	0.1219	0.1108	0.1589	0.1435	0.2024	0.1988	0.2909	0.2206	0.1755	0.1165	0.1166	0.1756	0.1534	rs745894						
19	17049245	17049245	G	A	exonic	CPAMD8		synonymous SNV	CPAMD8:NM_015692:exon23:c.C2946T:p.V982V	2.01801525841884e-14	0.999974749452667	2.52505473128029e-05	C3 and PZP like, alpha-2-macroglobulin domain containing 8	.	.	TISSUE SPECIFICITY: Highly expressed in the kidney, brain and testis and to a lower extent in heart, liver and small intestine. {ECO:0000269|PubMed:15177561}.; 	unclassifiable (Anatomical System);ovary;cartilage;fovea centralis;choroid;lens;retina;prostate;optic nerve;lung;endometrium;larynx;placenta;bone;macula lutea;visual apparatus;iris;testis;head and neck;kidney;brain;	.	0.10307	0.10452	2.440614487	98.54918613	4982.63255	14.40066	19p13.11		0.0214	0.1806	0.0164	0.0389	0	0.0005	0.016	0.0163	0.0494	0.1641	0.0203	0	0.0395	0	0.0005	0.0112	rs61133226						
19	17081790	17081790	G	A	exonic	CPAMD8		synonymous SNV	CPAMD8:NM_015692:exon18:c.C2265T:p.D755D	2.01801525841884e-14	0.999974749452667	2.52505473128029e-05	C3 and PZP like, alpha-2-macroglobulin domain containing 8	.	.	TISSUE SPECIFICITY: Highly expressed in the kidney, brain and testis and to a lower extent in heart, liver and small intestine. {ECO:0000269|PubMed:15177561}.; 	unclassifiable (Anatomical System);ovary;cartilage;fovea centralis;choroid;lens;retina;prostate;optic nerve;lung;endometrium;larynx;placenta;bone;macula lutea;visual apparatus;iris;testis;head and neck;kidney;brain;	.	0.10307	0.10452	2.440614487	98.54918613	4982.63255	14.40066	19p13.11		0.0359	0.0038	0.1148	0.2505	0.0303	0.0067	0.0315	0.0075	0.0225	0.0033	0.0692	0.0099	0.2516	0.0301	0.0053	0.0153	rs74937996						
19	40199914	40199914	C	G	exonic	LGALS14		nonsynonymous SNV	LGALS14:NM_020129:exon4:c.C381G:p.F127L,LGALS14:NM_203471:exon5:c.C468G:p.F156L	0.0100122793683261	0.823537378881487	0.166450341750187	lectin, galactoside-binding, soluble, 14	FUNCTION: Binds beta-galactoside and lactose. Strong inducer of T- cell apoptosis. {ECO:0000269|PubMed:19497882}.; 	.	TISSUE SPECIFICITY: Highly expressed in placenta. {ECO:0000269|PubMed:11997112, ECO:0000269|PubMed:19497882}.; 	whole body;ovary;placenta;liver;parathyroid;spleen;	dorsal root ganglion;superior cervical ganglion;placenta;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.07595	0.11822	1.148343558	92.42745931	495.28106	4.57413	19q13.2		0.6416	0.7881	0.3840	0.3491	0.6924	0.6812	0.6542	0.7001	0.6899	0.7835	0.4436	0.6987	0.3248	0.7095	0.6868	0.6421	rs10755						
19	47200439	47200439	T	C	exonic	PRKD2		nonsynonymous SNV	PRKD2:NM_001079882:exon8:c.A821G:p.N274S,PRKD2:NM_016457:exon9:c.A1292G:p.N431S,PRKD2:NM_001079880:exon10:c.A1292G:p.N431S,PRKD2:NM_001079881:exon10:c.A1292G:p.N431S	0.9996964074254	0.000303592457339082	1.17260401134187e-10	protein kinase D2	FUNCTION: Serine/threonine-protein kinase that converts transient diacylglycerol (DAG) signals into prolonged physiological effects downstream of PKC, and is involved in the regulation of cell proliferation via MAPK1/3 (ERK1/2) signaling, oxidative stress- induced NF-kappa-B activation, inhibition of HDAC7 transcriptional repression, signaling downstream of T-cell antigen receptor (TCR) and cytokine production, and plays a role in Golgi membrane trafficking, angiogenesis, secretory granule release and cell adhesion. May potentiate mitogenesis induced by the neuropeptide bombesin by mediating an increase in the duration of MAPK1/3 (ERK1/2) signaling, which leads to accumulation of immediate-early gene products including FOS that stimulate cell cycle progression. In response to oxidative stress, is phosphorylated at Tyr-438 by ABL1, which leads to the activation of PRKD2 without increasing its catalytic activity, and mediates activation of NF-kappa-B. In response to the activation of the gastrin receptor CCKBR, is phosphorylated at Ser-244 by CSNK1D and CSNK1E, translocates to the nucleus, phosphorylates HDAC7, leading to nuclear export of HDAC7 and inhibition of HDAC7 transcriptional repression of NR4A1/NUR77. Upon TCR stimulation, is activated independently of ZAP70, translocates from the cytoplasm to the nucleus and is required for interleukin-2 (IL2) promoter up-regulation. During adaptive immune responses, is required in peripheral T-lymphocytes for the production of the effector cytokines IL2 and IFNG after TCR engagement and for optimal induction of antibody responses to antigens. In epithelial cells stimulated with lysophosphatidic acid (LPA), is activated through a PKC-dependent pathway and mediates LPA-stimulated interleukin-8 (IL8) secretion via a NF- kappa-B-dependent pathway. During TCR-induced T-cell activation, interacts with and is activated by the tyrosine kinase LCK, which results in the activation of the NFAT transcription factors. In the trans-Golgi network (TGN), regulates the fission of transport vesicles that are on their way to the plasma membrane and in polarized cells is involved in the transport of proteins from the TGN to the basolateral membrane. Plays an important role in endothelial cell proliferation and migration prior to angiogenesis, partly through modulation of the expression of KDR/VEGFR2 and FGFR1, two key growth factor receptors involved in angiogenesis. In secretory pathway, is required for the release of chromogranin-A (CHGA)-containing secretory granules from the TGN. Downstream of PRKCA, plays important roles in angiotensin-2- induced monocyte adhesion to endothelial cells. Plays a regulatory role in angiogenesis and tumor growth by phosphorylating a downstream mediator CIB1 isoform 2, resulting in vascular endothelial growth factor A (VEGFA) secretion. {ECO:0000269|PubMed:14743217, ECO:0000269|PubMed:15604256, ECO:0000269|PubMed:16928771, ECO:0000269|PubMed:17077180, ECO:0000269|PubMed:17951978, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:18262756, ECO:0000269|PubMed:19001381, ECO:0000269|PubMed:19192391, ECO:0000269|PubMed:23503467}.; 	.	TISSUE SPECIFICITY: Widely expressed.; 	lymphoreticular;umbilical cord;ovary;colon;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;oesophagus;bone;thyroid;iris;testis;amniotic fluid;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;blood;lens;skeletal muscle;bile duct;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;hypopharynx;liver;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;thymus;	prostate;superior cervical ganglion;lung;heart;thyroid;ciliary ganglion;trigeminal ganglion;whole blood;thymus;	0.09498	0.26572	-0.731092527	14.13658882	199.04525	3.04956	19q13.32																								
21	33067241	33067241	G	C	exonic	SCAF4		nonsynonymous SNV	SCAF4:NM_001145444:exon9:c.C1076G:p.P359R,SCAF4:NM_001145445:exon10:c.C1121G:p.P374R,SCAF4:NM_020706:exon10:c.C1121G:p.P374R	0.999999693301169	3.06698830689798e-07	5.9189509665223e-18	SR-related CTD associated factor 4	FUNCTION: May act to physically and functionally link transcription and pre-mRNA processing. {ECO:0000250}.; 	.	.	myocardium;ovary;colon;choroid;retina;uterus;prostate;endometrium;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;urinary;blood;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.76390	0.10408	-1.214341017	5.67940552	104.06406	2.20474	21q22.11		8.243e-05	0	0	0.0012	0	0	0	0	0.0002	0	0	0	0.0037	0	0	0	rs199790277						
21	38563725	38563725	G	A	exonic	TTC3		synonymous SNV	TTC3:NM_001330681:exon31:c.G4185A:p.K1395K,TTC3:NM_001330682:exon31:c.G4185A:p.K1395K,TTC3:NM_001001894:exon40:c.G5115A:p.K1705K,TTC3:NM_001330683:exon40:c.G5115A:p.K1705K,TTC3:NM_003316:exon40:c.G5115A:p.K1705K,TTC3:NM_001320703:exon41:c.G5235A:p.K1745K,TTC3:NM_001320704:exon41:c.G5169A:p.K1723K	5.39422630787731e-20	0.999708411976551	0.00029158802344859	tetratricopeptide repeat domain 3	FUNCTION: E3 ubiquitin-protein ligase that mediates the ubiquitination and subsequent degradation of phosphorylated Akt (AKT1, AKT2 and AKT3) in the nucleus. Acts as a terminal regulator of Akt signaling after activation; its phosphorylation by Akt, which is a prerequisite for ubiquitin ligase activity, suggests the existence of a regulation mechanism required to control Akt levels after activation. Catalyzes the formation of 'Lys-48'- polyubiquitin chains. May play a role in neuronal differentiation inhibition via its interaction with CIT. {ECO:0000269|PubMed:17488780, ECO:0000269|PubMed:20059950}.; 	.	TISSUE SPECIFICITY: Found in all tissues examined.; 	ovary;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;amniotic fluid;germinal center;brain;amygdala;heart;cartilage;tongue;pharynx;blood;lens;skeletal muscle;breast;trabecular meshwork;macula lutea;visual apparatus;liver;spleen;mammary gland;salivary gland;developmental;intestine;colon;fovea centralis;choroid;uterus;whole body;cerebral cortex;larynx;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;muscle;bile duct;pancreas;lung;cornea;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;cerebellum;	amygdala;superior cervical ganglion;testis - interstitial;occipital lobe;medulla oblongata;thalamus;hypothalamus;temporal lobe;caudate nucleus;pons;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;cingulate cortex;parietal lobe;pituitary;	0.33574	0.08857	-0.972178525	8.911299835	2405.24665	9.10751	21q22.13		0.3656	0.3235	0.2307	0.5217	0.3411	0.3331	0.4330	0.5354	0.3289	0.3171	0.2667	0.3255	0.5199	0.3484	0.3112	0.3745	rs2835655						
22	30860830	30860830	C	T	exonic	SEC14L3		nonsynonymous SNV	SEC14L3:NM_174975:exon8:c.G641A:p.R214H,SEC14L3:NM_001257379:exon9:c.G464A:p.R155H,SEC14L3:NM_001257382:exon9:c.G464A:p.R155H,SEC14L3:NM_001257378:exon10:c.G410A:p.R137H	4.21057781805564e-18	0.000739736343451667	0.999260263656548	SEC14 like lipid binding 3	FUNCTION: Probable hydrophobic ligand-binding protein; may play a role in the transport of hydrophobic ligands like tocopherol, squalene and phospholipids.; 	.	.	unclassifiable (Anatomical System);optic nerve;lung;nasopharynx;macula lutea;liver;spleen;fovea centralis;choroid;lens;nose;retina;	subthalamic nucleus;superior cervical ganglion;uterus corpus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.33148	0.11968	1.155610133	92.59259259	7730.11725	18.91651	22q12.2		0.2157	0.2228	0.1442	0.3250	0.2889	0.2170	0.1795	0.1711	0.2332	0.2242	0.1599	0.2384	0.3076	0.2832	0.2217	0.2490	rs2269961						
22	39907941	39907941	G	C	exonic	MIEF1		nonsynonymous SNV	MIEF1:NM_001304564:exon4:c.G232C:p.G78R,MIEF1:NM_019008:exon4:c.G232C:p.G78R	0.0628938325307641	0.921465905895044	0.0156402615741921	mitochondrial elongation factor 1	FUNCTION: Mitochondrial outer membrane protein which regulates mitochondrial fission. Promotes the recruitment and association of the fission mediator dynamin-related protein 1 (DNM1L) to the mitochondrial surface independently of the mitochondrial fission FIS1 and MFF proteins. Regulates DNM1L GTPase activity and DNM1L oligomerization. Binds ADP and can also bind GDP, although with lower affinity. Does not bind CDP, UDP, ATP, AMP or GTP. Inhibits DNM1L GTPase activity in the absence of bound ADP. Requires ADP to stimulate DNM1L GTPase activity and the assembly of DNM1L into long, oligomeric tubules with a spiral pattern, as opposed to the ring-like DNM1L oligomers observed in the absence of bound ADP. Does not require ADP for its function in recruiting DNM1L. {ECO:0000269|PubMed:21508961, ECO:0000269|PubMed:21701560, ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:23530241, ECO:0000269|PubMed:23921378, ECO:0000269|PubMed:24515348}.; 	.	TISSUE SPECIFICITY: Expression is relatively high in heart, skeletal muscle, pancreas and kidney. {ECO:0000269|PubMed:21701560}.; 	.	.	0.12261	0.09986	0.420771676	77.15852795	1019.99486	6.14357	22q13.1		0.0046	0.0004	8.642e-05	0.0613	0	9.003e-05	0.0077	0.0009	0.0039	0.0003	0.0012	0	0.0723	0	0	0	rs2272830						
22	41605809	41605809	G	C	exonic	L3MBTL2		nonsynonymous SNV	L3MBTL2:NM_031488:exon2:c.G134C:p.S45T	0.0130280434479328	0.986911838666868	6.01178851992325e-05	l(3)mbt-like 2 (Drosophila)	FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. {ECO:0000269|PubMed:19233876}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;testis;amniotic fluid;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;muscle;lens;bile duct;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;stomach;thymus;	superior cervical ganglion;ciliary ganglion;	0.30184	0.10643	-1.172055164	6.027364945	286.32425	3.62314	22q13.2		0.0011	9.61e-05	0.0006	0.0116	0	5.993e-05	0.0011	0.0010	0.0008	0.0002	0	0	0.0130	0	0.0002	0	rs150194965						
22	42076330	42076330	G	A	exonic	SNU13		synonymous SNV	SNU13:NM_001003796:exon2:c.C42T:p.A14A,SNU13:NM_005008:exon3:c.C42T:p.A14A	.	.	.	SNU13 homolog, small nuclear ribonucleoprotein (U4/U6.U5)	FUNCTION: Binds to the 5'-stem-loop of U4 snRNA and may play a role in the late stage of spliceosome assembly. The protein undergoes a conformational change upon RNA-binding. {ECO:0000269|PubMed:10545122, ECO:0000269|PubMed:17412961}.; 	.	TISSUE SPECIFICITY: Ubiquitous.; 	.	.	0.34688	.	0.035072054	56.2514744	.	.	22q13.2		0.0241	0.0507	0.0671	0.0220	0.0203	0.0077	0.0209	0.0463	0.0244	0.0523	0.0597	0.0066	0.0234	0.0146	0.0093	0.0193	rs6002436						
